What's new

India's COVID-19 vaccine mega-drive - will it succeed?

I was referring to the claim that Covaxin is better against the Indian variant.

It’s too early to make such claims and the only data released shows Covaxin and Covishield to be identical in effectiveness against reinfection.

By the science bit, I was referring to the claim that Covaxin being based off an inactivated virus makes it more potent.

Is there any scientific basis to such a claim?

A lot of the love for Covaxin seems to come from Modi allegedly having taken it. There are older people in my family who delayed taking their shot so that they could get Covaxin because Modi got it apparently.

I personally think he actually took the Oxford one :)

Ok then we are on the same page.
 
Ventilators are among more than 600 pieces of life-saving medical equipment being sent from the UK to India as the country battles a surge in COVID-19 cases.

Prime Minister Boris Johnson has vowed to "stand side by side" with India as it struggles with its highest numbers of new daily coronavirus cases to date since the pandemic began.

On Sunday - for the fourth day in a row - India set a new global record for daily COVID infections.

India's health ministry reported 349,691 cases on Sunday, bringing the total to 16.96 million, second only to the US.

The surge in cases has been accompanied by severe shortages of medical oxygen in some areas, with hospitals warning they could run out within hours.

Following discussions with Indian ministers, the UK is sending a first shipment of supplies on Sunday - due to arrive in New Delhi in the early hours of Tuesday - with further shipments to follow.

In total, nine airline container loads of supplies - including 495 oxygen concentrators, 120 non-invasive ventilators and 20 manual ventilators - will be sent to India from the UK this week.

Mr Johnson, who had been due to visit India this week but cancelled his trip amid the surge in COVID cases, said: "We stand side by side with India as a friend and partner during what is a deeply concerning time in the fight against COVID-19.

"Vital medical equipment, including hundreds of oxygen concentrators and ventilators, is now on its way from the UK to India to support efforts to prevent the tragic loss of life from this terrible virus.

"We will continue to work closely with the Indian government during this difficult time and I'm determined to make sure that the UK does everything it can to support the international community in the global fight against pandemic."

The Department of Health and Social Care worked with the NHS, as well as UK suppliers and manufacturers, to identify reserve supplies that could be sent to India.

And ministers will work closely with their Indian counterparts to decide what further aid could be sent in the coming days.

Health Secretary Matt Hancock said: "The heart-breaking scenes in India show once again how awful this terrible disease is.

"We are determined to support the people of India through this very difficult time, and I am hugely grateful to those who have worked hard to make this initial delivery happen.

"This first delivery of life saving equipment will provide much needed assistance and we stand ready to do more."

Oxygen and medical supplies are also set to be sent to India from the EU, after European Commission President Ursula von der Leyen said she was "alarmed" by the situation.

The White House has indicated that support will also be coming from Washington - and oxygen tanks have already been loaded on to aircraft in Singapore to be flown into India.

Meanwhile, tankers carrying oxygen supplies have been transported by train across India.

Footage was released of a train transporting vehicles laden with liquid oxygen from Bokaro to Lucknow on Sunday.

Railways minister Piyush Goyal dubbed the train the "Oxygen Express".

Separate footage has shown police delivering oxygen cylinders to a hospital in capital New Delhi.

Max Healthcare, which runs a network of hospitals in northern India, said it could run out in under two hours as it posted an "SOS" message on Twitter.

Another big chain, Fortis Healthcare, said it was "running on backup".

"Every hospital is running out. We are running out," Dr Sudhanshu Bankata, executive director of Batra Hospital in the capital, told New Delhi Television.

https://news.sky.com/story/uk-to-se...xygen-crisis-amid-record-covid-surge-12286883
 
New Delhi: Registration for the newly eligible category - those aged above 18 - for COVID-19 vaccination has begun on Wednesday as the country gears up for the launch of the third phase of vaccination drive from 1 May.

All those above 18 years of age can now register themselves on the CoWIN portal or using the Aarogya Setu app to get vaccinated against COVID-19.

India has been struggling with the second wave of coronavirus infection that has triggered a severe shortage of medical oxygen and hospital beds in several states.
 
Inshallah. And hopefully Pakistan takes live lessons from it and also successfully
Does for own population
 
Vaccination centres close in Mumbai as India posts another record rise in Covid-19
All vaccination centres in India’s financial capital of Mumbai were shut for three days starting Friday due to a shortage of vaccines, said authorities, as the country posted another record daily rise in coronavirus cases.

India reported 386,452 news cases on Friday, while deaths from Covid-19 jumped by 3,498 over the last 24 hours, according to health ministry data.

However, medical experts believe actual Covid-19 numbers in the world’s second-most populous nation may be five to 10 times greater than the official tally.

India has added about 7.7 million cases since the end of February, when its second wave picked up steam, according to a Reuters tally. In contrast, it took India nearly six months to add the previous 7.7 million cases.

The country is in deep crisis, with hospitals and morgues overwhelmed, medicines and oxygen in short supply and strict curbs on movement in its biggest cities.

India is the world's biggest producer of vaccines but does not have enough stockpiles to keep up with the second deadly Covid-19 wave, despite Prime Minister Narendra Modi's government planning to vaccinate all adults starting May 1. Only about 9% of India's 1.4 billion people have received a vaccine dose since January.

Several states have said they will be unable to immunize people aged 18-45 immediately.

Modi is scheduled to meet the cabinet of ministers on Friday as the wave of infections cripples the nation's health system and threatens to impact major businesses as absenteeism grows with staff falling sick or taking leave to tend to sick relatives.

World aid has started arriving in India as it struggles to combat what has been described as a humanitarian disaster.

The first US flight carrying oxygen cylinders, regulators, rapid diagnostic kits, N95 masks and pulse oximeters arrived in the Indian capital Delhi on Friday.

"Just as India came to our aid early in the pandemic, the US is committed to working urgently to provide assistance to India in its time of need," US Secretary of State Antony Blinken said on Twitter.

"Today we are proud to deliver our first shipment of critical oxygen equipment, therapeutics and raw materials for vaccine production."

OXYGEN CRISIS TILL MID-MAY

The United States will send more than $100 million in medical aid, including 1,000 oxygen cylinders, 15 million N95 masks and 1 million rapid diagnostic tests. It also has redirected its own order of AstraZeneca supplies to India, to allow it to make more than 20 million doses.

Shipments from other countries continued to pour in, with a third one from the United Kingdom reaching earlier in the day. Romania and Ireland also sent supplies late on Thursday.

India’s severe medical oxygen supply crisis is expected to ease by mid-May, a top industry executive told Reuters, with output rising by 25% and transport infrastructure ready to cope with a surge in demand.

A worker died and at least two were injured after an oxygen cylinder exploded during refilling at Panki Oxygen refilling plant in Kanpur in India's northern state of Uttar Pradesh earlier on Friday, local police told Reuters.

The incident comes a week after at least 22 patients died at a public hospital in India’s western Maharashtra state when their oxygen supply ran out after a leak in the tank.

India will receive a first batch of Russia's Sputnik V vaccine on May 1. Russia's RDIF sovereign wealth fund, which markets Sputnik V globally, has signed deals with five Indian manufacturers for more than 850 million vaccine doses a year.

Prominent US disease modeller Chris Murray, from the University of Washington, said the sheer magnitude of infections in India in a short period of time suggests an "escape variant" may be over powering any prior immunity from natural infections in those populations.

"That makes it most likely that it’s B.1.617," he said. But Murray cautioned that gene sequencing data on the coronavirus in India is sparse, and that many cases are also being driven by the UK and South African variants.

Carlo Federico Perno, Head of Microbiology and Immunology Diagnostics at Rome's Bambino Gesù Hospital, said the Indian variant couldn't alone be the reason for India's huge surge, pointing instead to large social gatherings.

Modi has been criticised for allowing massive political rallies and religious festivals which have been super-spreader events in recent weeks.

https://tribune.com.pk/story/2297585/vaccination-centres-close-in-mumbai-as-india-posts-another-record-rise-in-covid-19
 
India has become the first country to report more than 400,000 new coronavirus cases in a single day, as its nationwide vaccine drive launches amid a supply crisis.

Some 3,523 deaths were officially recorded in the past 24 hours - but the real figure is thought to be far higher as many fatalities go unreported.

As of today, all adults in India are eligible to be vaccinated.

But several states say they don't have the doses to carry out the exercise.

India had previously focused on vaccinating frontline workers and the over-45s. The country is facing acute shortages of medical oxygen and hospital beds, as a devastating second wave of coronavirus batters its health system.

Meanwhile, a fire at a hospital in the western city of Bharuch killed 12 people in the early hours of Saturday, the latest in a number of deadly hospital fires across the country this week.

How is India's rollout going?
About 150 million shots have been given, equivalent to 11.5% of India's 1.3 billion people.

Despite being the world's biggest producer of vaccines, the country is suffering an internal shortage and has placed a temporary hold on all exports of AstraZeneca to meet domestic demand.

More than 13 million people aged 18-45 have registered for the jab, but states including central Madhya Pradesh and hard-hit Maharashtra have said they will not start vaccinating this age group on 1 May as planned due to supply problems.

Delhi Chief Minister Arvind Kejriwal asked people not to queue up for injections as the Indian capital had not yet received doses.

"As soon as vaccines arrive we will let you know, then you can come for shots. We appeal to you not to crowd vaccine centres in the next few days," Mr Kejriwal said.

"Many across the country have registered for vaccines but we have not received stocks. We are in regular touch with companies and we hope to get the vaccines in a day or two."

Since the pandemic began, India has confirmed more than 18 million cases and over 200,000 deaths. It has the second-highest number of Covid-19 infections in the world after the United States.

The US has said it will restrict travel from India, beginning on 4 May, to try to stop the spread of Covid-19. Australia has gone a step further, making it temporarily illegal for its citizens to return home from India.

Experts believe India should ramp up vaccination in areas of high transmission and in five states where elections are being held.

Bhramar Mukherjee, a biostatistician at the University of Michigan, told the BBC the country needed to administer 10 million shots daily "instead of being complacent with three million" doses a day.

"I do feel frustrated that India did not roll out the vaccination drive more aggressively while the curve was in its valley," Dr Mukherjee said.

Which vaccines is India using?

India has been using two vaccines - the Oxford-AstraZeneca jab (known locally as Covishield) and another made by Indian firm Bharat Biotech (Covaxin).

The Russian-made Sputnik V vaccine has also been approved for use, and the first doses are expected to arrive on Saturday. It's not yet clear how large the shipment will be.

Earlier this week, Brazil's health regulator refused permission for Sputnik V to be imported there, citing concerns about its development and safety. The vaccine's developer called the move political and said it would sue the regulator.

Who is paying for the vaccines?

Vaccination is voluntary. State-run clinics and hospitals are offering free jabs, but people can also pay 250 rupees ($3.4; £2.4) a dose at private facilities.

From 11 April, the government allowed people to get paid jabs at private and state-run workplaces.

The government is spending around $5bn to provide free doses at state-run clinics, public health centres and hospitals.

People can experience side effects from vaccines.

India has a 34-year-old surveillance programme for monitoring "adverse events" following immunisation. Experts say a failure to transparently report such incidents could lead to fear-mongering around vaccines.

India has so far reported 18,904, "adverse events" after vaccination. Most of these events were "minor" - anxiety, vertigo, giddiness, dizziness, fever, and pain - and all patients had recovered, the government said.

The surveillance programme has examined 617 cases of "severe adverse events", including 180 deaths after vaccination until March, according to reports.

It found the "deaths happened in cases where the person had underlying conditions, including heart problems, high blood pressure and diabetes".

BBC
 
Provided over 16 crore Covid-19 vaccine doses to states free of charge: Centre

As the younger population of India becomes eligible for vaccination against coronavirus today with the start of the third phase of inoculation drive, Centre said that over 79 lakh Covid-19 vaccine doses are still available with the states and union territories to be administered to their population.

The Centre has so far provided over 16.37 crore Covid vaccine doses to States and Union Territories free of cost and another 17 lakh doses will be received by them in the next 3 days, the Union health ministry said on Saturday.

As the younger population of the nation becomes eligible for vaccination against coronavirus today with the start of the third phase of inoculation drive, the ministry said that more than 79 lakh vaccine doses are still available with the states and union territories to be administered to their population.

As many as 16,37,62,300 Covid-19 vaccine doses have been provided to states and union territories (UTs) free of cost as per data available till 8am on Saturday, the ministry said.

Out of 16,37,62,300 Covid-19 vaccines, the total consumption including wastages is 15,58,48,782 doses, the ministry stated.

Maharashtra has received the maximum number of vaccines followed by Uttar Pradesh and Rajasthan.

Lakshadweep has reported the highest percentage of vaccine wastage with 9.76% followed by Tamil Nadu at 8.83%, Assam at 7.70%, Manipur at 7.44%, and Haryana at 5.72%.

The highest balance availability of doses is with Uttar Pradesh amounting to 12,10,220 doses.

"As was prescribed in the liberalised and accelerated Phase-3 strategy of Covid-19 vaccination, all the states and UTs have been intimated by the Union ministry of health and family welfare regarding the total number of vaccine doses that they would receive as part of the "Government of India channel", of the vaccine doses totally free of cost for the vaccination of 45 years and above beneficiaries," read the release.


https://www.hindustantimes.com/india-news/provided-over-16-crore-covid-19-vaccine-doses-to-states-free-of-charge-centre-101619859686234.html
 
Covaxin trials approved in children between 2 and 18 years

The approval has been granted for testing the vaccine on children between 2 and 18 years of age. The subject expert committee of the central drugs standard control organisation on Tuesday approved trials, with certain conditions, officials aware of the matter confirmed

Bharat Biotech has received approval from India’s drugs regulator to conduct clinical trials on children for its coronavirus disease (Covid-19) vaccine, Covaxin, making it the first Covid-19 vaccine to be tested on kids in India.

The approval has been granted for testing the vaccine on children between 2 and 18 years of age. The subject expert committee (SEC) of the central drugs standard control organisation (CDSCO) on Tuesday approved trials, with certain conditions, officials aware of the matter confirmed.

“The panel approval is for the phase II/III trials under certain conditions,” an official privy to the matter confirmed, on the condition of anonymity.

Also Read | Scientists race to study variants in India as Covid cases explode

According to reports, the trial is planned to be conducted among 525 participants at multiple locations. The hospitals include All India Institute of Medical Sciences (AIIMS), Delhi, and AIIMS in Patna.

The aim of conducting the trials will be to evaluate the Covaxin vaccine in children for safety, reactogenicity and immunogenicity. All these parameters are necessary for granting approval for use in masses.

MORE FROM THIS SECTION
During the period of house arrest, Navlakha was not allowed to meet anybody and even the NIA did not have access to him. For this reason too, the HC supported the argument advanced by NIA to deny any relief to Navlakha.
News updates from HT: SC reserves order on Gautam Navlakha’s bail plea

Soumya Santosh was on a video call with her family members when the strike took place.
'Heart goes out to 9-yr-old son,' Israel's India envoy speaks to Soumya's family

Srinagar: Security personnel patrol on a street during pandemic induced curfew in Srinagar on Tuesday (PTI)
Covid curfew relaxations scrapped in Srinagar after large-scale violations

A CRPF personnel stands guard during lockdown imposed in Jammu and Kashmir by administration to contain the surge in Covid-19 cases, in Srinagar.
Day after Eid shoppers violate Covid lockdown norms, curbs increased in Kashmir

Covaxin is the first Make in India Covid-19 vaccine that Bharat Biotech co-developed with the Indian Council of Medical Research (ICMR). It is a whole virion inactivated vaccine.

Bharat Biotech had approached the national drugs regulator with a proposal to test its Covaxin vaccine on children between 5 and 18 years of age, but the company was asked to come back with the efficacy data of its vaccine in adults first before testing the vaccine on children.

It was also asked to submit a revised clinical trials protocol for children in the SEC meeting of CDSCO on February 24.

As part of the SEC recommendation, the company has been asked to submit the interim safety data of phase II clinical trials along with the data safety and management board recommendations to the CDSCO before it intends to proceed to seek permission for the phase III part of the trials.

Currently, Pfizer-BioNTECH Covid-19 vaccine has been approved by US FDA for use on children between 12 and 15 years in the US.

https://www.hindustantimes.com/india-news/bharat-biotech-gets-approval-to-conduct-covaxin-clinical-trials-on-kids-101620803970878.html
 
India's coronavirus death count crossed 2,50,000 on Wednesday in the deadliest 24 hours since the pandemic began, as the disease rampaged through the countryside, leaving families to weep over the dead in rural hospitals or camp in wards to tend the sick.
Boosted by highly infectious variants, the second wave erupted in February to inundate hospitals and medical staff, as well as crematoriums and mortuaries. Experts still cannot say for sure when the figures will peak.

State leaders clamoured for vaccines to stop the second wave and the devastation that it has wrought, urging Prime Minister Narendra Modi to help them procure urgent supplies from overseas.

Deaths grew by a record 4,205 while infections rose 3,48,421 in the 24 hours to Wednesday, taking the tally past 23 million, health ministry data showed. Experts believe the actual numbers could be five to 10 times higher.

Funeral pyres have blazed in city parking lots, and bodies have washed up on the banks of the holy river Ganges, having been immersed by relatives whose villages were stripped bare of the wood needed for cremations.

Lacking beds, drugs and oxygen, many hospitals in the world's second-most populous nation have been forced to turn away droves of sufferers, while tales of desperate relatives searching for someone to treat dying loved ones have become sickeningly commonplace.

Although the infection curve may be showing early signs of flattening, new cases are likely to fall off slowly, according to virologist Shahid Jameel.

"We seem to be plateauing around 400,000 cases a day," the Indian Express newspaper quoted him as saying. "It is still too early to say whether we have reached the peak."

Indians need vaccines "here and now", West Bengal Chief Minister Mamata Banerjee, said in a letter to PM Narendra Modi. India has fully vaccinated barely 2.5% of the population.

Delhi had run out of its reserves of shots and had to close down several centres, Deputy Chief Minister Manish Sisodia told reporters.

India is using the AstraZeneca vaccine made at the Serum Institute in the western city of Pune and Covaxin by Bharat Biotech but production is well short of the millions of doses required.

The country accounts for half of COVID-19 cases and 30% of deaths worldwide, the World Health Organization said in its latest weekly report.

The full impact of the B.1.617 variant found in India, which the WHO has designated as being of global concern, is not yet clear, it added.

British Prime Minister Boris Johnson said his government was looking at all possible solutions to tackle a surge in cases of the coronavirus variant first detected in India, including in the northern English town of Bolton.

"It may be more transmissible ... maybe even considerably more transmissible," he told parliament.

Rural Spread

Daily infections are shooting up in the Indian countryside in comparison to big towns, where they have slowed after last month's surge, experts say.

More than half the cases this week in Maharashtra were in rural areas, up from a third a month ago. That share is nearly two-thirds in the most populous, and mainly rural, state of Uttar Pradesh, government data showed.

Television showed images of people weeping over the bodies of loved ones in ramshackle rural hospitals while others camped in wards tending to the sick.

A pregnant woman was taking care of her husband who had breathing difficulties in a hospital in Bhagalpur in the eastern state of Bihar, which is seeing a case surge its health system could barely have handled at the best of times.

"There is no doctor here, she sleeps the whole night here, taking care of her husband," the woman's brother told India Today television.

In a corridor outside, two sons were wailing over the body of their father, saying repeatedly that he could have been saved if only he had been given a bed in an intensive care unit.

At the general hospital in Bijnor, a town in northern Uttar Pradesh, a woman lay in a cot next to a garbage can and medical waste.

"How can someone get treated if the situation is like this?" asked her son, Sudesh Tyagi. "It is a hell out here."

NDTV
 
India Covid: Do reinfections pose a challenge to vaccines?

Three weeks after he had been fully vaccinated against the coronavirus, a science journalist in Delhi developed high fever, a sore throat and a general feeling of discomfort.

On 22 April, Pallava Bagla tested positive for the coronavirus. Four days later, a chest scan showed his clear lungs turning white, a sign of infection.

As the fever persisted, he was admitted to hospital - eight days after his first symptoms.

At the All India Institute of Medical Sciences, doctors put Mr Bagla, 58, through blood tests and administered steroids. As he had an underlying condition - diabetes - his blood sugar soared. Luckily, his oxygen levels never fell perilously low.

Before he left the hospital after eight days, doctors showed him a scan of the lungs of an unvaccinated, diabetic, male Covid-19 patient of his age, and compared it to his scan.

"The difference was clear. The doctors told me that if I had not taken the vaccine I would have probably landed up on the ventilator in critical care. Timely and full vaccination saved my life," Mr Bagla says.

Although India has fully vaccinated a paltry 3% of its 1.3 billion people, breakthrough cases - people contracting the infections two weeks after being fully vaccinated - appear to be rising.

Health workers - doctors, nurses, hospital and clinic workers - have borne the brunt of such infections so far. Mr Bagla appeared to be an exception to the rule, so scientists took swabs from his nose and throat to crack the genetic code of the virus which infected him.

The aim is find answers to a question scientists are grappling with: Are our existing vaccines - two in the case of India - protecting us enough from newer and often more transmissible variants of the coronavirus?

Coronavirus vaccines are indisputably effective. Although they don't prevent infection, they protect people against severe illness and death by even the most dangerous variants of the virus.

So "vaccine breakthrough infections" are not unexpected.

Of the 95 million people fully vaccinated in the US until 26 April, 9,045 developed breakthrough infections, according to the Centers for Disease Control and Prevention (CDC).

Eight hundred and thirty five (9%) were hospitalised and 132 (1%) died. Nearly a third of the hospitalised patients and 15% of the deaths were reported as "asymptomatic or not related to Covid-19".

Thanks to poor data, the evidence in India is still patchy.

There are reports of a rising number of breakthrough infections with a large number of healthcare workers infected after being fully vaccinated, and even a few deaths. But whether the infection directly caused the deaths is unclear.

Vaccination rates have slowed down because of a shortage of doses

Official figures claim two to four persons in every 10,000 vaccinated people in India have had a breakthrough infection. But the data appears to be incomplete: for three months those getting tested weren't asked whether they had been vaccinated.

Evidence from hospitals is mixed.

Dr Vincent Rajkumar, a professor of the Mayo Clinic in the US, says he spoke to two major state-run hospitals in Tamil Nadu in southern India and found that a very "small fraction" of their vaccinated workers had contracted the infection. "The few who had it had quickly recovered," he told me.

On the other hand, 60% of doctors in the intensive care unit in Lok Nayak Jai Prakash Narayan (LNJP) Hospital, Delhi's largest Covid-19 hospital, were infected after being fully vaccinated, but none required hospitalisation, according to Dr Farah Husain, a critical care specialist. "Some of the members of their families got sick and needed hospitalisation," she said.

A study in another Delhi hospital, Fortis C-DOC, found 15 of 113 vaccinated health workers got the infection two weeks after the second dose. Fourteen of the cases were mild, and only one required hospitalisation.

"We are seeing a lot of breakthrough infections among health workers. But most of them are mild. Vaccines are blocking severe infection," says Dr Anoop Misra, a diabetologist and a co-author of the study.

India is reeling from a deadly second wave of infections

Swabs taken from six fully vaccinated healthcare workers who suffered from breakthrough infections in the state of Kerala were recently sequenced for a study.

Two of the patients had been infected by variants which had mutations that bypassed the body's immunity, but none of the cases developed severe disease, according to Dr Vinod Scaria, a leading geneticist and one of the study's authors.

Scientists say India needs much more data to check the prevalence of such infections in the general population, and to find out more about how the vaccines are working.

"The question that people are now frequently asking is whether it is true that a large number of people are getting re-infected after their vaccinations," says Dr Shahid Jameel, a virologist.

"Such anecdotal reports cause a lot of anguish in the minds of people who want to get vaccinated."

The bigger worry is that the daily vaccination rates in India are slipping and herd immunity appears to be far away. (Herd immunity happens when a large portion of a community becomes immune to a disease through vaccination or through the mass spread of the disease.) Vaccine reluctance can make matters worse.

Scientists say that India's deadly and uncontrolled second wave will make it easier for the virus to mutate, with the more contagious ones likely to escape the immunity offered by vaccines.

Sequencing to track viral mutations will remain the key to prepare for future waves of infection.

The bottom line, scientists say, is that vaccines - with varying degrees of efficacy - are protecting against severe disease and hospitalisation.

But since the fully vaccinated can still get infected and infect others, safeguards should not be lowered - masking up, avoiding crowded social gatherings and poorly-ventilated, air-conditioned workspaces - for a long time to come.

Double masking, for example, should be made mandatory, as India's Kerala state has done. Public health messaging, which has been largely confusing so far, has to be precise: Can fully vaccinated people, for example, gather freely indoors, at homes and workplaces?

"Vaccines work. But they don't give you the licence to be reckless and let down your guard. You must remain very cautious," Mr Bagla says. He should know.

https://www.bbc.com/news/world-asia-india-57084572.amp
 
To put everything in perspective india has actually vaccinated 175 million until now. Its like vaccinating a country like Australia 5 times. Due to scale of indian population it does not look ok to many
 
Dr Fauci: India’s decision to extend gap between Covishield doses is reasonable

Dr Anthony Fauci said the Indian government's decision to increase the gap between Covishield doses was unlikely to have a negative effect on vaccine efficacy.

The Indian government’s decision to extend the duration between the first and second dose of the Covishield vaccine is a “reasonable approach”, the United States’ top infectious disease expert Dr Anthony Fauci said in an interview to news agency ANI. Fauci said the government’s move would help ensure that more people receive at least one dose of the vaccine.

“When you are in a very difficult situation, the way you are in India, you have to try and figure out ways to get as many people vaccinated as quickly as you can, so I believe that it is a reasonable approach to do,” Fauci told ANI. “It is unlikely that a long delay would have a negative effect on vaccine efficacy.”

This comes after the Centre on Thursday announced that it was extending the interval between two doses of the Covishield vaccine from six-eight weeks to 12-16 weeks, citing “real-life evidence” from the UK. Covishield accounts for 90 per cent of the 17.8 crore vaccine doses administered so far.

According to Fauci, India should collaborate with other countries to help ramp up its own vaccine capabilities. Calling India one of the best vaccine producers in the world, Fauci said it was important for the country to “use some resources for your people”.

WATCH When you don’t have enough vaccines, extending duration b/w 1st & 2nd dose to get more people to at least get 1st dose is a reasonable approach. Unlikely that long delay would’ve negative effect on vaccine efficacy: Dr Anthony Fauci, top US infectious disease expert to ANI

“It’s a very very large country with a population of about 1.4 billion people. You only have a couple of percentage of the people who are fully vaccinated and over about 10 per cent or so have had at least one dose so you’ve got to work out arrangements with other countries, other companies at the same time as ramping up your own capability of making vaccines because as you know, India is one of the best if not the biggest vaccine producer in the world,” Dr Fauci told ANI.

With Russia’s Sputnik V vaccine likely to be rolled out as early as next week, Dr Fauci said the vaccine “seems to be quite efficacious, at a high level of close to 90 per cent or so”. He urged rich countries and countries with the capability of making and distributing vaccines to act on their “moral responsibility” to assist poorer countries that are struggling to inoculate their population.

For over a month now, India has been grappling with an aggressive second wave of the coronavirus pandemic, which has overwhelmed its already-feeble healthcare system and claimed thousands of lives. Fauci recommended the country rope in the services of the Indian Armed Forces in its fight against Covid-19.

Vaccine passport isn’t going to be mandated from federal standpoint in US. Travel is going to depend on level of infection. India has very high level of infection. It’d be difficult to resume travel there right now: Dr Anthony Fauci, top US infectious disease expert to ANI


“You can use the military sometimes to get things done quickly that you otherwise in the private sector would not be able to, for example, I know that there’s a shortage of hospital beds right now that people who need to be in a hospital or not getting into a hospital because of the shortage of the beds, you can get the military to put up field hospitals, the same way they would during time of war, that could serve as a substitute for the classic hospital.” Dr Fauci told ANI.

Addressing the issue of travelling amidst the second wave, the infectious disease expert said that resumption of travel to India is unlikely and would be difficult given the high level of infection in the country.

On Thursday, India laid out a vaccine roadmap for the rest of the year. Over two billion doses of Covid-19 vaccines could become available for India between August and December this year, according to estimates given by vaccine manufacturers, the government said. Meanwhile, the government said global manufacturers Pfizer, Moderna and Johnson & Johnson have indicated that they would be able to open discussions only in “Q3, 2021”.

https://indianexpress.com/article/india/anthony-fauci-india-covishield-vaccine-doses-covid-7314745/
 
How India's vaccine drive went horribly wrong

It took 31-year-old Sneha Marathe half a day to book an appointment online for a Covid vaccine.

"It was a game of 'fastest finger first'," she says. "The slots filled up in three seconds." But the hospital cancelled her slot at the last minute: they had no vaccines. Ms Marathe went back to try for another appointment.

All 18-44 year-olds in India have to register on the government's CoWin platform to get vaccinated. With demand for jabs far outstripping supply, tech-savvy Indians are even writing code to corner elusive appointments.

Ms Marathe can't code, but she is among millions of Indians who are on the right side of the country's digital divide - unlike hundreds of millions of others who don't have access to smartphones or the internet, currently the only route to a jab.

Prime Minister Narendra Modi's federal government has opened up vaccinations for some 960 million eligible Indians without having anything close to the required supply - more than 1.8 billion doses.

Worse, the severe shortage comes amid a deadly second Covid wave and warnings of an impending third wave.

A cocktail of blunders - poor planning, piecemeal procuring and unregulated pricing - by Mr Modi's government has turned India's vaccine drive into a deeply unfair competition, public health experts told the BBC.

How did the world's largest vaccine manufacturer, often dubbed the "pharmacy of the world" for generic drugs, end up with so few vaccines for itself?

A piecemeal strategy

"India waited till January to place orders for its vaccines when it could have pre-ordered them much earlier. And it procured such paltry amounts," says Achal Prabhala, a co-ordinator with AccessIBSA, which campaigns for access to medicines in India, Brazil and South Africa.

Between January and May 2021, India bought roughly 350 million doses of the two approved vaccines - the Oxford-AstraZeneca jab, manufactured as Covishield by the Serum Institute of India (SII), and Covaxin by Indian firm Bharat Biotech. At $2 per dose, they were among the cheapest in the world, but not nearly enough to inoculate even 20% of the country's population.

Declaring that India had defeated Covid, Mr Modi even took to "vaccine diplomacy", exporting more jabs than were administered in India by March.

Contrast that with the US or EU, who pre-ordered more doses than they required nearly a year before the vaccines became available for immunisation.

"This guaranteed vaccine manufacturers a market, gave them certainty to forecast supply and sales, and ensured that some of these governments got large quantities as quickly as possible, once the vaccines were ready," Mr Prabhala says.

Unlike the US and the UK, India also waited until 20 April - well into the second wave - to extend a $610m financing line to SII and Bharat Biotech to boost production.

Another failure, according to Malini Aisola, co-convener of the All India Drug Action Network, was the decision not to enlist the vast swathe of India's manufacturing capabilities - biologics factories, for instance, that could have been repurposed into vaccine production lines.

Again, four firms, including three government-owned ones, have only recently been given rights to make Covaxin, which is partially publicly-funded.

On the other hand, by early April, Russian developers of Sputnik V, had inked manufacturing deals with a host of Indian pharma companies, which are set to produce the vaccine.

A fractured market
As the sole buyer initially, the federal government could have held far greater leverage over pricing, Ms Aisola says.

"Centralised bulk procurement would have allowed the price to come down from $2. Instead it has gone up," she adds.

This is because since 1 May, it has been up to individual states and private hospitals to broker their own deals with manufacturers.

Opposition parties have called it a "scam", saying the federal government had abdicated its responsibility, opening up "debilitating competition among states".

States have to pay double - $4 - the federal government's rate for a dose of Covishield and four times as much for Covaxin - $8. This was after the two companies lowered prices for states as a "philanthropic gesture". States are also competing for scarce stocks alongside private hospitals, which can pass on the costs to customers.

The result: a veritable free market for vaccines that have been developed and manufactured with both public and private funding. At private hospitals, a single dose can now cost up to 1,500 rupees ($20; £14).

Several states have now announced plans to import other vaccines from Pfizer, Moderna and Johnson & Johnson. But no manufacturer is able to guarantee supply in the next few months since richer countries have pre-ordered stocks.

Sputnik V has been approved, but it's still unclear when the vaccines will be rolled out.

Should India's vaccines cost so much?
Some have accused SII and Bharat Biotech of "profiteering" during a pandemic, especially after receiving public funding.

But others say they took substantial risks and that the fault lies with the government. India is the only country where the federal government is not the sole buyer, and one of the few where vaccinations are not free.

But public health experts agree that SII and Bharat Biotech need to be more transparent about their manufacturing costs and their commercial contracts.

Ms Aisola says SII needs to disclose how it spent the $300m it received from the international Covax scheme and the Gates Foundation, funding which was meant to finance vaccines for low-income countries. SII has failed to do so, partly because India banned exports. The company is also fielding a legal notice from AstraZeneca for defaulting on its promise to send 50% of its supply to low-income countries.

Public health experts are also calling for scrutiny of the Indian government's contract with Bharat Biotech, especially since the Indian Council of Medical Research has said it "shares" intellectual property (IP) for Covaxin, which it developed along with the company. But the jab costs more - often double - than Covishield.

"They say they share IP but what sort of an agreement did they sign? Does it give them [the government] the right to override any clauses in case of an emergency?" asks Dr Anant Bhan, a public health expert.

While India has supported waiving the patents on foreign-made vaccines, it has made no move to suspend it for Covaxin.

Contrary to its international position, it has opposed suggestions from opposition leaders to invoke compulsory licensing and allow other pharma companies to manufacture the approved vaccines, saying these measures would prove "counterproductive".

Dr Bhan agrees that at this stage it would take time to transfer technology and build capacity in other pharma companies - but he also says it's unclear why none of this was attempted earlier.

Chart showing how India's vaccine drive ranks globally.
Vaccinating even 70% of India's 1.4 billion people was always going to be a long exercise in planning and patience. But given the country's strong record on immunisation, it was not an impossible task, Dr Bhan says.

However, why the government chose to rely on just two companies who can now control supply and dictate prices is a question that few have answers to.

BBC
 
90 lakh doses/day will be needed in August- December to achieve target

Over these 120 days, it has administered about 18 crore doses, an average of 15
lakh doses a day

The government has projected the possible availability of 200 crore doses of Covid vaccines during August-December and said it should be possible to vaccinate India’s entire adult population by year-end.
Here’s a look at the numbers that would need to be delivered for this target to be achieved.

Having started vaccination on Jan 15, India has completed four months or 120 days of vaccination on Friday, May 14. Over these 120 days, it has administered about 18 crore doses, an average of 15 lakh doses a day. To fully vaccinate an adult population estimated at just under 94 crore, according to census projections, it would need to administer a further 170 crore doses in the remaining 231 days of the year.

That would require an average of 73.6 lakh doses a day, weekends included, a nearly fivefold increase over the average so far.

Of course, the average for the four months so far is lowered by the initial phase in which daily vaccination levels were much lower. But even if we take the last week, the average has been only somewhat higher at 17 lakh doses a day.

By the government’s own estimates, the supply situation for vaccines will significantly improve only by July-end. In other words, over the next two-and-a-half months, the average daily vaccination is unlikely to be dramatically higher than the current levels. For all of May, for instance, the states are to be allocated a total of 6.12 crore doses (combining their direct procurement from manufacturers and what
they get from the Centre) as per the Centre’s affidavit in the Supreme Court. The private sector should get another 2 crore taking the total for the month to just over 8 crore.

It seems reasonable to assume, therefore, that the average vaccination stays at about 25 lakh doses a day in May.

In June, the government expects total supplies to reach 10 crore and in July 15 crore doses.
Assuming these supplies do indeed come through, by July end, or over the next 78 days, India would have administered another 33 crore doses. That would still leave 137 crore doses to be administered between Aug 1 and Dec 31, a period of 153 days.

That is an average of over nearly 90 lakh doses a day, seven days a week. No country so far has managed even a single day of half this level of vaccination and India’s highest, also the highest in the world, has been 41.6 lakh doses on Apr 5. Maintaining an average of 90 lakh would mean more than double that peak every day for five months.

Vaccinating 90 lakh crore people a day is not merely a challenge of supplies. It would mean adding many more vaccination centres than have been used at any point in the vaccination drive and finding the extra personnel needed to man them and to administer the doses. Even if it is possible to add centres, there is still the challenge of finding extra personnel.

Of course, this would be a moot question if the anticipated supplies don’t materialize. Experts agree that the projection of 2 billion doses by year end is quite optimistic. It would mean all existing manufacturers reaching their projected scaled-up capacity by end of July and vaccines currently in trial stage or pending
approval coming through in time.

https://timesofindia.indiatimes.com/india/90-lakh-doses/day-will-be-needed-in-august-december-to-achieve-target/articleshow/82644530.cms
 
<blockquote class="twitter-tweet" data-partner="tweetdeck"><p lang="en" dir="ltr">Such were the vaccine diplomacy ambitions that India’s UN representative proudly informed the United Nations General Assembly that India has supplied more COVID-19 vaccines globally than vaccinated its own people 14/n <a href="https://t.co/xvyB34uzVn">pic.twitter.com/xvyB34uzVn</a></p>— SamSays (@samjawed65) <a href="https://twitter.com/samjawed65/status/1393752783124406277?ref_src=twsrc%5Etfw">May 16, 2021</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>
 
A big failure and was just an image building exercise for feku, nothing else!
 
<blockquote class="twitter-tweet" data-partner="tweetdeck"><p lang="en" dir="ltr">Such were the vaccine diplomacy ambitions that India’s UN representative proudly informed the United Nations General Assembly that India has supplied more COVID-19 vaccines globally than vaccinated its own people 14/n <a href="https://t.co/xvyB34uzVn">pic.twitter.com/xvyB34uzVn</a></p>— SamSays (@samjawed65) <a href="https://twitter.com/samjawed65/status/1393752783124406277?ref_src=twsrc%5Etfw">May 16, 2021</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>
Which conclusively proves yet again that this feku led regime has blood of countless Indians on its hands!
 
DRDO’s 1st batch of anti-Covid drug 2DG launched


The drug will be the “first indigenous research-based outcome” to fight the virus, and will “reduce recovery time and oxygen dependency” in the country, Vardhan said at the launch.


Defence Minister Rajnath Singh and Health Minister Harsh Vardhan at the launch today. (ANI)
The first batch of anti-COVID drug 2-DG, developed by the DRDO was released on Monday by Defence Minister Rajnath Singh and Health Minister Harsh Vardhan.

The drug will be the “first indigenous research-based outcome” to fight the virus, and will “reduce recovery time and oxygen dependency” in the country, Vardhan said at the launch.

The approval comes as India continues to grapple with a continuous surge in a deadly second wave. The healthcare system has stretched and there are huge gaps in the supply and demand of medical oxygen.

The Drugs Controller General of India (DGCI) earlier this month approved the oral drug for emergency use as an adjunct therapy in moderate to severe coronavirus patients.

The clinical trials of the drug, 2-deoxy-D-glucose (2-DG) showed that it hastens the recovery process and supplemental oxygen dependence, the health ministry said.

The anti-COVID therapeutic application of the drug has been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS) in collaboration with Dr. Reddy’s Laboratories (DRL) in Hyderabad.

The drug comes in powder form in a sachet and is taken orally by dissolving it in water, the ministry said.

“In the ongoing second COVID-19 wave, a large number of patients are facing severe oxygen dependency and need hospitalisation. The drug is expected to save precious lives due to the mechanism of its operation in the infected cells. This also reduces the hospital stay of COVID-19 patients,” the ministry had said.

https://indianexpress.com/article/india/first-batch-of-anti-covid-drug-2-dg-launched-7318435/
 
Nearly 2 Crore COVID-19 Vaccine Doses Available With States: Centre

COVID-19 Vaccine India: "Nearly 2.00 crore (1,97,70,555) COVID-19 vaccine doses are still available with the states and UTs to be administered," the Union Health Ministry said.

Nearly two crore COVID-19 vaccine doses are still available with states and union territories while around 26 lakh are being made and will be received by them within the next three days, the Union health ministry said today.
Vaccination is an integral pillar of the comprehensive strategy of the government of India for containment and management of the pandemic along with test, track, treat and COVID-appropriate behaviour, it said.

As part of the nationwide vaccination drive, the central government said it has been supporting the states and union territories by providing them COVID-19 vaccines free of cost.

"The government of India has so far provided, both through the free of cost category and through direct state procurement category, more than 21 crore vaccine doses (21,07,31,130) to states and UTs. Of this, the total consumption (including wastage) is 19,09,60,575 doses (as per data available at 8 am today)," the ministry said.

"Nearly 2.00 crore (1,97,70,555) COVID-19 vaccine doses are still available with the states and UTs to be administered," it said.

"Furthermore, nearly 26 lakh (25,98,760) vaccine doses are in the pipeline and will be received by the states and UTs within the next three days," it added.

The government has also been facilitating the direct procurement of vaccines by the states and union territories.

Implementation of the Liberalised and Accelerated Phase 3 Strategy of COVID-19 Vaccination started from May 1. Under this strategy, every month, 50 per cent of the total Central Drugs Laboratory (CDL) cleared vaccine doses of any manufacturer would be procured by the Centre. It would continue to make these doses available to the state governments totally free of cost as was being done earlier, the ministry said.

https://www.ndtv.com/india-news/nearly-2-crore-covid-19-vaccine-doses-available-with-states-union-territories-centre-2445744
 
75% Indians don’t know how to get vaccinated. UP, Bihar, MP, Rajasthan fare worst

It is now evident that vaccination is the only way for India to defeat the coronavirus. The Narendra Modi government’s vaccination policy has come under severe criticism for its multi-pricing strategy, lack of supply, arbitrary change of rules of vaccination intervals, etc.

But underlying all this is the process of getting oneself vaccinated. And for that, there is only CoWIN — the government’s app and online portal solely managing the vaccination drive.

Perhaps, all readers of this column are aware of CoWIN and the process for registration for vaccination. But as ThePrint-Prashnam Vox Pop series has repeatedly shown, we are not representative of the nation.

So, what percentage of Indians actually know about the vaccination process? This is what we set out to find this week.

We asked two questions to 2,248 adult Indians across seven states – Bihar, Gujarat, Kerala, Madhya Pradesh, Maharashtra, Rajasthan, and Uttar Pradesh, covering 246 districts:

If you want to get vaccinated, what is the process to follow?

Take the help of your local leader
A government officer will visit my area to vaccinate us
Have to register on a government platform or app
I don’t know
What is CoWIN?

It is a government scheme to give money to the poor
It is a government scheme to give ration to people
It is an app to register for vaccination
I don’t know

Respondent profile
Of the 2,248 adult Indians who responded to this survey, 68 per cent were male and 32 per cent female; 66 per cent were youth (<40 years), 24 per cent middle-aged, and 9 per cent seniors (>60).

The all-India number is calculated based on the population weighted average of the seven states surveyed.

Results
Seventy-five per cent of adult Indians DO NOT know the process to get vaccinated.

Vast majority of the people surveyed didn’t know that the process of vaccination is to register on the government app or portal. Thirty per cent people think that a government official will visit them to vaccinate. While 13 per cent think that they will have to take help of a local leader.

Not surprisingly, more people in Kerala (43 per cent) and Maharashtra (37 per cent) knew the correct process for vaccination. In Bihar, Uttar Pradesh, Madhya Pradesh and Rajasthan, only 14 per cent of those surveyed knew how to get vaccinated.

Contrary to what one would expect, there is no significant difference in awareness levels between urban and rural districts. Seventy per cent in urban districts are unaware of the vaccination procedure while 76 per cent in rural districts are unaware.

Except for people in Bihar (50 per cent) and Madhya Pradesh (47 per cent), a good number of people from the other five states knew about CoWIN — 64 per cent in Gujarat and 89 per cent in Uttar Pradesh.

But given that 75 per cent of the adult populace does not know about the vaccination process, the central and state governments have a huge responsibility of raising awareness. Political parties with their vast ground network and civil society organisations that have the trust of the people can also play a pivotal role in raising awareness, and help people register for vaccination on CoWIN.

Even if the Modi government manages to solve the vaccine shortage problem sometime soon, India may still lag behind in the goal to vaccinate the entire adult population if people remain unaware about the vaccination process.

https://theprint.in/opinion/75-indi...ated-up-bihar-mp-rajasthan-fare-worst/660670/
 
Have always maintained that this vaccination program was a sham right from the start.

Apart from pathetically low number of people who've been vaccinated in last 4.5 months since this drive started, this article conclusively proves it is and it'll remain a sham till the time this publicity and control hungry changes its vaccination strategy in totality.
 
Australia batting legend Matthew Hayden recently penned an emotional note for India that is currently battling a deadly second wave of coronavirus pandemic. Opening up on what prompted him to pour his heart out, Hayden said he feels a special connection with India which has taught him many lessons over the years.

In his blog, Hayden had urged the world media to not pass any judgement without understanding the challenges that come with the successful implementation of any public scheme in a country that has a billion-plus population.

Hayden, who has been India on several occasions when representing Australia as a player and even now in the capacity of a commentator, says he feels a special connection with the people of this country.

“I just felt sympathetic to a country that has personally given me so many lessons more than anything,” Hayden told CNN-News18 in an exclusive interview. “I have often described to people all over the world that whenever I am in India, there’s this special connection that I have with the broader community of people, not just cricket lovers but people right across (India) that have this vibrancy and this life and commitment to excellence.”

“Coming from that place, I felt so upset and also frustrated. Some of the challenges that India were facing (compared to other countries),” he added.

Hayden was struck by the ‘sudden, eerie silence’ that a country bustling with humanity had come as a response to coronavirus and hopes things will change for good soon.

“All this life of of just extreme intensity of humanity and then all of a sudden an eerie silence in response to covid and I also had an extraordinary respect (as to) the people were listening. It was just an opportunity for me to just to pen down what I was thinking and feeling at the time and hoping it would shift in a positive direction,” the 49-year-old said.


Hayden also took a shot at those being critical of how India has handled the pandemic saying without having an understanding to the complexities, people were passing judgement and he felt very strongly about it.

“India is a comprehensive society with so many layers to it, Language, religion, different foods even. Simply just throwing stones with limited understanding, I felt very strongly about it. But I also understand that coming from this side of the fence that it is very difficult to understand until you have seen and I just feel privileged to have been in India as a traveler and as a brother and sister for almost three decades. I have a privileged position on that,” he said.

He continued, “It’s amazing how words can be weapon but can be positive as well. We as a community are linked through our consciousness and our ability to process that how we will be able to live in a new normal world of covid. One of the great and powerful words is empathy.”

He also talked about the connection between India and Australia that goes well beyond their shared love of cricket. “As Australians, we are very much brothers and sisters of India. We have 7,00,000 families living in Australia. I believe we have delivered somewhere close to 15 tonnes of medical supplies to India, 3,000 ventilators and a hundred Oxygen ventilators. There is a fantastic linkage. It started with our common ground for the love of cricket but it goes well beyond that. Hopefully my words were helping,” he said.

https://www.news18.com/cricketnext/...tics-of-indias-covid-19-response-3759908.html
 
"Pfizer, Moderna Won't Sell Shots To Us. They Said...": Arvind Kejriwal

Arvind Kejriwal's statement comes a day after Punjab said Moderna has refused to sell vaccines to the state directly.

New Delhi: US pharmaceutical giants Pfizer and Moderna have made it clear they won't sell vaccines directly to Delhi, Chief Minister Arvind Kejriwal said today, stressing that vaccine manufacturers have underlined "they will deal with the central government". Vaccine rollout for the 18-44 age group was paused on Saturday in Delhi due to the shortage of doses.
"We've spoken to Pfizer and Moderna for vaccines, and both the manufacturers have refused to sell vaccines directly to us. They have said they will deal with the central government. We appeal to the centre to import vaccines and distribute to the states," Mr Kejriwal told reporters this afternoon.

His statement comes a day after Punjab said Moderna has refused to sell vaccines to the state directly. The Amarinder Singh government had reached out to all such manufacturers, according to officials, looking for direct purchases.

Arvind Kejriwal on Saturday wrote to Prime Minister Narendra Modi, seeking an increase in the supply of doses. "Every month, Delhi needs 80 lakh doses but it received only 16 lakh doses in May. For June, our share has been reduced further to eight lakh doses," he said.

In his letter, Mr Kejriwal also gave four suggestions to the Prime Minister on speeding vaccine drive. "The centre should speak to international vaccine manufacturers, buy from them and distribute to states. States and union territories are fighting with each other," he said.

International vaccine manufacturers should be given permission to manufacture in India, he added, and he also insisted that the countries that have stocked more vaccines than they need should send excess doses to India.

"All vaccine makers in India, within 24 hours, should be ordered to manufacture Bharat Biotech's Covaxin to ramp up stocks," he appealed to the centre.

Lockdown in Delhi was extended for the sixth straight week on Sunday even as the city saw positivity rate dropping to less than 2.5 per cent. The national capital, which witnessed hospitals buckling under the pressure of India's second Covid wave in the last few weeks, saw 1,649 new cases.

India has so far cleared three vaccines for emergency use: Bharat Biotech's homegrown Covaxin, Serum Institute of India's Covishield, developed in partnership with the Oxford University and British pharma giant AstraZeneca, and Russia's Sputnik V. Several states have announced they would try to buy vaccines directly from international manufacturers.

https://www.ndtv.com/india-news/coronavirus-pfizer-moderna-refused-to-sell-vaccines-to-us-said-they-will-talk-to-the-central-government-says-arvind-kejriwal-2448245
 
Wockhardt offers to make 2 billion Covid vaccine doses a year

Outside of India, Wockhardt already has an agreement with the UK government to “fill and finish” Covid-19 vaccines exclusively for the UK.

Indian pharmaceutical company Wockhardt has told the government it can produce as many as two billion doses a year of most Covid-19 vaccines, starting with a capacity of 500 million doses by February 2022.

In a formal submission to the Centre earlier this month, Mumbai-based Wockhardt has sought help to identify potential partners in the country whose vaccines it could produce, The Indian Express has learnt. It is also in the process of “accessing” some of the technology to make Covid-19 vaccines. It has told the government it has the manufacturing and research capability to create a diversified portfolio that would allow it to produce and supply mRNA, protein-based and viral vector-based vaccines.

The government is examining the company’s offer. Queries to Wockhardt remained unanswered by press time Tuesday.

In a recent presentation at a seminar organised by Swadeshi Jagran Manch, Minister of State for Chemicals and Fertilisers Mansukh L Mandaviya had said, “Wockhardt had last week told us it also wants to tie up with any company (for manufacturing Covid-19 vaccines). So, we are also working on that. We will get them tied up with one of the companies.”

https://indianexpress.com/article/india/wockhardt-offers-to-make-2-billion-covid-vaccine-doses-a-year-7330263/
 

New Delhi: US pharmaceutical giants Pfizer and Moderna have made it clear they won't sell vaccines directly to Delhi, Chief Minister Arvind Kejriwal said today, stressing that vaccine manufacturers have underlined "they will deal with the central government". Vaccine rollout for the 18-44 age group was paused on Saturday in Delhi due to the shortage of doses.


What is the logic behind Pfizer refusing to sell to State Governments that can afford to buy it ?
 
What is the logic behind Pfizer refusing to sell to State Governments that can afford to buy it ?

pfizer / moderna wont sell to states - only to governments and also they want indemnity for the future:

<iframe width="560" height="315" src="https://www.youtube.com/embed/mOpTvxpTezI" title="YouTube video player" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture" allowfullscreen></iframe>
 
MUMBAI (Reuters) - Indian doctors on Wednesday decried the free distribution of an unproven remedy to COVID-19 patients by the state of Haryana as the maker of the herbal medicine faced a backlash over comments in which he said modern medicine had caused deaths.

The northern state, which is ruled by Prime Minister Narendra Modi’s Bharatiya Janata Party, said this week it would hand out Coronil to COVID-19 patients. The ayurvedic medicine was launched by yoga guru Baba Ramdev’s company Patanjali Ayurved last year to much fanfare as a COVID-19 cure.

The government later said the consumer goods company co-founded by Ramdev could not market the drug as a cure, and it needed to market it as an immunity booster.

There is no scientific basis to Coronil’s use in treating COVID-19 patients, said Ajay Khanna, the state secretary of the Indian Medical Association (IMA) in Uttarakhand, where Patanjali is headquartered.

“If the Haryana government is doing this, then it is their loss,” he told Reuters in a telephone interview, referring to the state’s distribution of the remedy.

The Uttarakhand unit of IMA filed a lawsuit against the yoga guru, asking him to write an apology for his recent statement that science-based treatments had caused the deaths of thousands of COVID-19 patients.

The comment drew the ire of doctors across the country and Ramdev, who has a large following in India, withdrew his remarks on Sunday.

“He is more of a businessman than anything else. To sell his product, he has sparked a fight between allopathic medicine and ayurveda,” Khanna said.

Ayurveda is an ancient Indian system that includes medicines, meditation, exercise and dietary guidelines practiced by millions of adherents.

The outcry over the remedy and the guru’s comments comes weeks after Indian doctors warned against the practice of smearing cow dung on the body in the belief it will ward off COVID-19, saying there was no scientific evidence of its effectiveness and it risked spreading other diseases.

India’s has had 27.16 million cases of the coronavirus and 311,388 deaths, according to health ministry data, and a devastating second wave of infections is sweeping many parts of the country.

Traditional medicine is popular with many people, partly because of a lack of access to healthcare, but doctors have warned of the danger of people putting their trust in alternative treatments for COVID-19.

“You lower your guard thinking you’re protected in some way, but I think real harm can be caused by giving people a false sense of security,” said Lancelot Pinto, a consultant pulmonologist at Hinduja Hospital in Mumbai.
 
"Even Their Baap Can't Arrest Me": Ramdev On Feud With Doctors

Ramdev's remarks about allopathy had triggered an outcry from doctors across the country and he was forced to "withdraw" them this week.

Dehradun: Roasted for his disparaging remarks against allopathy and modern medicine, yoga guru Ramdev on Thursday was seen in another controversial video on social media, challenging calls for his arrest, saying "even their baap (father) cannot arrest Swami Ramdev".
"They are just making a noise. They keep creating trends like Thug Ramdev, Mahathug Ramdev, Giraftar Ramdev and so on," he said responding to #Arrest Ramdev trends on social media.

"Arrest to khair unka baap bhi nahin kar sakta Swami Ramdev ko (even their father cannot arrest Swami Ramdev)," he was heard saying in the video.

Ramdev, the face of one of India's biggest consumer goods and alternative medicine empires, has faced widespread criticism for saying in a video that surfaced over the weekend that more people died of modern medical treatments during the COVID-19 crisis than the coronavirus itself.

"Lakhs of people have died because of allopathic medicines, far more than those who died because they did not get treatment or oxygen," Ramdev said in the video from an event. He also purportedly called allopathy a "stupid and bankrupt" science.

The remarks triggered an outcry from doctors across the country and Ramdev was forced to "withdraw" them via a Tweet following a letter from Union Health Minister Harsh Vardhan. However, Ramdev has shown little remorse for the statements since and has found ways to repeat them on TV debates and public platofrms.

The Indian Medical Association (IMA), which represents 3.5 lakh doctors, has written to Prime Minister Narendra Modi demanding that Ramdev be charged immediately for sedition for a misinformation campaign on coronavirus vaccination and challenging government protocols for its treatment.

The top medical body of doctors has also served a defamation notice on Ramdev for his remarks against allopathy and allopathic practitioners, demanding an apology from him within 15 days, failing which it said it will demand a compensation of ₹ 1,000 crore from the yoga guru.

https://www.ndtv.com/india-news/ramdev-on-feud-with-doctors-even-their-baap-cant-arrest-me-2450401
 
This thug has become too big for his boots! Blame squarely lies at the door of the bigot who used him for his electoral gains and is still using him.
 
Any other guy would've been slapped with multiple sedition cases by now but not this fake who knows quite a few secrets of these fascists.
 
What is the logic behind Pfizer refusing to sell to State Governments that can afford to buy it ?

only central govt can make these contracts.

pfizer wants indemnity bond which central govt has refused to give.
 
BJP supporters say ‘won’t forgive’ Modi for COVID ‘indifference’

New Delhi, India – On April 29, Amit Jaiswal, a member of the Rashtriya Swayamsevak Sangh (RSS), passed away in Mathura, a small town in Uttar Pradesh state, just three hours from the national capital.

The 42-year old died of COVID-19 ten days after testing positive. His grieving family said that despite repeated SOS tweets to Prime Minister Narendra Modi, who followed Jaiswal on Twitter, no assistance came.

The RSS, a far-right Hindu supremacist organisation founded in 1925, is the ideological fountainhead of Modi’s governing Bharatiya Janata Party (BJP) and counts the prime minister among millions of its members across India.

Jaiswal’s heartbroken family tore off Modi’s posters that he had pasted on his car, claiming they would “never forgive Modi for his indifference”.

“We are in a state of deep depression and can’t talk to anybody, nobody can help us,” his inconsolable sister Sonu Alagh told Al Jazeera two weeks later.

For many supporters who believed in Modi, his response to the pandemic has led to disillusionment.

Grief-stricken and angry at the avoidable deaths of their loved ones due to the coronavirus, thousands of Indians have heaped scornful criticism on Modi and his BJP, with the bitterness transcending barriers of religion, class, caste and politics.

Over the last two months, social media platforms including Facebook and Twitter have seen anti-Modi hashtags such as #ResignModi, #ModiFailsIndia and #ModiAgainstNation go viral.

But BJP politician Sudhanshu Mittal claims the government “did whatever we could” to fight the pandemic.

“When you tread an uncharted path there are no benchmarks to follow and nobody knew that this would be the catastrophic extent of the second wave,” he told Al Jazeera, adding that health is a “state subject” and that “some states are playing politics”.

“This is not the time for politics or blame-game. That can happen later,” Mittal said.

‘Won’t vote for Modi again’
Chetan Kaushal, a restaurateur who was forced to shut down his business due to the coronavirus lockdown last year, says he is one of those who voted for Modi despite demonetisation and “other faults” in his first term (2014-19) as prime minister.

Demonetisation refers to Modi’s controversial overnight banning of banknotes of higher denomination and issuing fresh notes in 2016, leading to huge chaos as people crowded ATMs and banks to withdraw their money.

“I believed he deserved a second chance but I don’t think I will vote for him ever again,” Kaushal told Al Jazeera.

The spectre of sudden and needless deaths seems to have triggered an unprecedented criticism even among Modi’s supporters.

Achyut Trivedi, a New Delhi-based marketing professional and active member of the BJP for the last 12 years, said “people like me are determined that we will not make the mistake of voting for Modi for the third time”.

“At least I won’t do it after what my family has gone through,” he told Al Jazeera.

Modi, who has faced international criticism over a crumbling economy and a perceptible decline in civil and political liberties, faces his biggest threat domestically as a vicious second COVID-19 wave rages across India.

Backed by his seemingly unwavering popularity at home, Modi in January this year told global leaders at the World Economic Forum that India “has saved humanity from a big disaster by containing Corona effectively”.

That premature claim was soon followed by India, the world’s largest vaccine maker, donating and exporting more than 66 million doses of the coronavirus vaccine to dozens of countries, a “vaccine diplomacy” now being widely criticised amid a severe shortage of the jab at home.

On March 7, Health Minister Dr Harsh Vardhan said India was “in the endgame of the pandemic”.

‘Picnic at a public hanging’
In February and March, despite the World Health Organization (WHO) warning of a new COVID-19 strain discovered in India as a “variant of concern”, Modi turned his attention towards regional elections in five states, including the eastern state of West Bengal where he and his BJP hoped to dislodge India’s only serving woman chief minister, Mamata Banerjee.

Throwing all caution to the wind, Modi addressed dozens of election rallies attended by tens of thousands of BJP supporters jostling among themselves amid a pandemic.

“Today, in all directions I only see huge crowds of people… I have witnessed such a rally for the first time,” Modi said at a rally in West Bengal’s Asansol city on April 17, even as the country reported more than 200,000 daily cases that day.

The BJP’s Mittal claims there is “no empirical evidence” to link the explosion in COVID-19 cases or deaths to poll campaigns.

“We can also say that the farmer agitation was responsible for cases as that too was a big agitation. I don’t think we can conclude that people are angry, that is a subjective matter depending on your perspective,” he told Al Jazeera.

Meanwhile, Modi’s maskless photograph appeared on the front pages of leading newspapers in April, inviting Hindu devotees to congregate for a weeks-long religious festival on the banks of the Ganges River in northern Uttarakhand state’s Haridwar town.

The Kumbh Mela, or pitcher festival, as the pilgrimage was called, saw nearly nine million visitors taking a holy dip in the river in less than three weeks, turning the event into a “super-spreader” of the virus and resulting in dozens of deaths across India.

“Despite warnings about the risks of super-spreader events, the government allowed religious festivals to go ahead, drawing millions of people from around the country, along with huge political rallies – conspicuous for their lack of COVID-19 mitigation measures,” medical journal Lancet wrote in a scathing indictment.

Amid the raging pandemic, critics have also lambasted Modi for going ahead with a $2.8bn “Central Vista” project to build a new parliament, prime minister’s residence and other federal buildings.

Senior journalist Nalini Singh told Al Jazeera the ongoing construction “is akin to having a picnic at a public hanging”.

‘What will crying achieve?’
Concerned at a growing public backlash against his government’s handling of the pandemic and “misplaced priorities”, Modi and his RSS colleagues took part in a meeting on May 23 to plan the strategy for next year’s state elections in Uttar Pradesh.

It was in this BJP-ruled northern state, also India’s most populous, that chilling images of bodies floating in the Ganges river and mass graves found along its banks made headlines around the world.
Headed by controversial saffron-clad Hindu monk Yogi Adityanath as the state’s chief minister, the BJP suffered serious reverses in local body elections held in April and May, despite the pandemic threatening the lives of the government workers deployed to hold the polls.

Last week, the Uttar Pradesh Primary Teachers Association said nearly 1,600 teachers died of COVID-19 after they were forced to work as polling officers.

“If the government had accepted our request to be vaccinated like other government employees who are battling COVID-19, so many of us wouldn’t have died,” Dinesh Chand Sharma, president of the teachers’ association, told Al Jazeera.

On Monday, police in Delhi “visited” Twitter offices to uncover details of why the social media giant had labelled a BJP spokesman’s tweets as “manipulated media”.

In his tweet, Sambit Patra had shared a purported “*******” prepared by the opposition Congress Party, which the BJP claimed was used to malign Modi.

On Thursday, Twitter said it was worried about the safety of its staff in India following the Delhi Police action.

Modi’s detractors accuse the Hindu nationalist leader of “manipulating narratives” through a “pliant and subservient media”, of targeting its opponents by using government agencies, and of remaining focused only on winning elections, often at the cost of governance.

Anand Singh, an affluent garment trader in Uttar Pradesh’s Varanasi, also Modi’s parliamentary constituency, says holding political rallies during a pandemic and the decision to go ahead with local body elections in the state was like “rubbing salt in our wounds”.

“I had never expected that we would have to go through such pain despite having wealth and social capital,” Singh told Al Jazeera.

Varanasi mirrored the experience in many parts of the country which saw a huge spike in COVID-related deaths, frantic appeals for oxygen cylinders, and disturbing images of bodies being cremated even in parking lots of crematoriums and lying in queues for final rites.

“I had my reservations about the BJP and Modi but I reasoned with myself and trusted his promise of development. Twice they were given an overwhelming mandate that could have been used to bring progress but there have been so many announcements and no execution,” a New Delhi-based entrepreneur who requested anonymity told Al Jazeera.

“It seems he is a man who wants power for power’s sake.”

In a recent online interaction with healthcare workers in Varanasi, Modi got emotional as he spoke. But reactions to the videos on social media sites of him choking saw more “dislikes”, with many calling him out for his “crocodile tears”.

“He cries despite being the prime minister. We have lost lives and business in this pandemic. We expected better from him,” said Singh.

“What will crying achieve?”

https://www.aljazeera.com/amp/news/...-covid-indifference?__twitter_impression=true
 
only central govt can make these contracts.

pfizer wants indemnity bond which central govt has refused to give.

why does india need pfizer or moderna? thought u said Covaxin is better ?- why are indians calling for pfizer / moderna
 
Coronavirus: Different vaccines given to 20 in India jab mix up:


Twenty people in north India have been given two different coronavirus jabs for their first and second doses.

They were given a shot of Covishield (AstraZeneca) in early April, but then got the locally developed Covaxin as part of their second dose in May.

India has not allowed the mixing of vaccines and studies are going on around the world to see if different doses can be safely administered.

Officials said the 20 people were healthy and had no side effects.

Officials in Siddharthnagar district in Uttar Pradesh state said they had launched an inquiry into the "administrative oversight".

Sandeep Chaudhary, Chief Medical Officer of Siddharthnagar, told the local NDTV news channel that he had asked for an explanation from "those who are guilty" and vowed to take action against them.

Some villagers said that they were afraid that the "vaccine cocktail" would have an adverse impact on them in the coming weeks.

Covaxin is an inactivated vaccine which means that it is made up of killed coronaviruses, making it safe to be injected into the body.

Meanwhile Covishield, which is the local name for the Oxford-AstraZeneca vaccine is being manufactured locally by the Serum Institute of India, the world's largest vaccine manufacturer. It is made from a weakened version of a common cold virus (known as an adenovirus) from chimpanzees. It has been modified to look more like coronavirus - although it can't cause illness and is safe.

Scientists are still studying if vaccines made on different platforms can be given to the same person. The "goof up" comes amid a severe shortage of vaccines doses across the country.

The government has opened vaccinations for everyone above the age of 18 but hasn't procured enough to speed up the drive.

The sluggishness of the drive has only exacerbated the impact of a devastating second wave of the virus that has overwhelmed hospitals and even crematoriums in recent weeks.

The mix up comes amid a raging second wave of the pandemic. It has become one the worst affected countries with more than 2.7 million cases.

It has also reported more than 300,000 deaths from the virus though experts fear the real number is many times higher.

https://www.bbc.co.uk/news/world-asia-india-57264622
 
why does india need pfizer or moderna? thought u said Covaxin is better ?- why are indians calling for pfizer / moderna

Its about giving people choice. Opposition parties asked the govt to allow states to procure any vaccine they want. Modi govt allowed it.

200mn plus doses of covishield and covaxin have been administered already. Many more to come. But if someone wants to fall for the PR of pfizer and wants it, he should have the choice.
 
Its about giving people choice. Opposition parties asked the govt to allow states to procure any vaccine they want. Modi govt allowed it.

200mn plus doses of covishield and covaxin have been administered already. Many more to come. But if someone wants to fall for the PR of pfizer and wants it, he should have the choice.

Pfizer is the best vaccine out there, it nothing to do with PR.

What is your opinion on Baba Ram Devs corona treatment (coronil). Do you endorse it?
 
Last edited:
Pfizer is the best vaccine out there, it nothing to do with PR.

What is your opinion on Baba Ram Devs corona treatment (coronil). Do you endorse it?

Many countries are doing without pfizer. Its efficacy and technique is similar to Moderna, yet you dont see that much PR for Moderna.

What do you think of the Chinese vaccines that pakistanis are getting?
 
Its about giving people choice. Opposition parties asked the govt to allow states to procure any vaccine they want. Modi govt allowed it.

200mn plus doses of covishield and covaxin have been administered already. Many more to come. But if someone wants to fall for the PR of pfizer and wants it, he should have the choice.

it isnt about choice, clearly you dont know what your on about
 
it isnt about choice, clearly you dont know what your on about

Can you name how many countries have administered more than 200mn doses?

You clearly have no idea sbout what's happening in India. Pfizer is out of the two biggest markets in the world, India and China. This is lobbying to get access to one of them, before domestic manufacturers flood the market and they are priced out.
 
Because it's a democratic country where people can voice their opinion.

itachi, why is ur nation asking for pfizer / moderna - over Covaxin ? it doesnt have anything to do with democratic nation- you say you can produce enough of covaxin, your officials have been this for ages.

Itachi you full know that pfizer / moderna are the two best around, nothing about democratic country
 
Can you name how many countries have administered more than 200mn doses?

You clearly have no idea about what's happening in India. Pfizer is out of the two biggest markets in the world, India and China. This is lobbying to get access to one of them, before domestic manufacturers flood the market and they are priced out.

1- just america+ india
2- i clearly do know whats happening in india, been watching your news and posting for people like yourself/ itachi actually been saying the oposite.
3- its not about lobbying, your population is awaking up about how poor india government been, and now yet again begging for pfizer / moderna vaccine, due to how poor covaxin is.

remember pfizer /moderna didnt ask to enter india /china market, you lot begged them - they have officially rejected india-due to only selling to government and not states
 
<iframe width="560" height="315" src="https://www.youtube.com/embed/XlSv1JB2c5Y" title="YouTube video player" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture" allowfullscreen></iframe>

looks like thr both entering the market, due to india needs them
 
itachi, why is ur nation asking for pfizer / moderna - over Covaxin ? it doesnt have anything to do with democratic nation- you say you can produce enough of covaxin, your officials have been this for ages.

Itachi you full know that pfizer / moderna are the two best around, nothing about democratic country

The whole nation isn't asking. Hundreds of people are standing in line in EACH CENTER to get vaccinated of Covaxin or covieshield.

SOME people are asking for pfizer.

Why? you should ask them because we are not the one who's asking.
 
The whole nation isn't asking. Hundreds of people are standing in line in EACH CENTER to get vaccinated of Covaxin or covieshield.

SOME people are asking for pfizer.

Why? you should ask them because we are not the one who's asking.

no, every research says pfizer / moderna are the two best and the rest do have major symptoms. but heres the truth itach the video below:
<iframe width="560" height="315" src="https://www.youtube.com/embed/q7pLWsrM4yo" title="YouTube video player" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture" allowfullscreen></iframe>
 
Pfizer is the best vaccine out there, it nothing to do with PR.

What is your opinion on Baba Ram Devs corona treatment (coronil). Do you endorse it?

mRna & viral vector vaccines (like pfizer, moderna, covishield) are perfect for a particular spike protein. I would bet my money on inactivated virus based vaccines like covaxin against mutations (especially those in the spike protein).
 
<iframe width="560" height="315" src="https://www.youtube.com/embed/XlSv1JB2c5Y" title="YouTube video player" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture" allowfullscreen></iframe>

looks like thr both entering the market, due to india needs them

India is going to vaccinate most of the population by December.

The name and the number of vaccines for months August to December has been published.

Covishield (Serum Institute) – 750 million; Covaxin (Bharat Biotech) – 550 million; Biological E’s subunit vaccine – 300 million; Zydus Cadila’s DNA vaccine – 50 million; Serum Institute’s Covavax – 200 million; Bharat Biotech’s nasal vaccine – 100 millionl Gennova’s mRNA vaccine – 60 million and Sputnik V’s 15 million. All produced in India.

Thats more than 2bn doses by December. So there is no urgency or need.but people have a choice to opt for pfizer or moderna etc.
 
India is going to vaccinate most of the population by December.

The name and the number of vaccines for months August to December has been published.

Covishield (Serum Institute) – 750 million; Covaxin (Bharat Biotech) – 550 million; Biological E’s subunit vaccine – 300 million; Zydus Cadila’s DNA vaccine – 50 million; Serum Institute’s Covavax – 200 million; Bharat Biotech’s nasal vaccine – 100 millionl Gennova’s mRNA vaccine – 60 million and Sputnik V’s 15 million. All produced in India.

Thats more than 2bn doses by December. So there is no urgency or need.but people have a choice to opt for pfizer or moderna etc.

most of those are bottom tier vaccines except mayb sputnik V and they're not trusted by the FDA, India is screwed unless they're able to get Pfizer or Moderna and that isn't happening until next year
 
In wake of concerns raised by civil society groups about the lack of vaccination facilities for Pakistani Hindu refugees, the Rajasthan high court took up the matter on Friday and said that the guidelines issued by the Centre in no way exclude such migrants when it comes to Covid-19 vaccination.

The Court also directed the state government to ensure that ration and food material be made available to all needy Pakistani migrants residing in various districts of Rajasthan.

The division bench of Justices Rameshwar Vyas and Vijay Bishnoi said in its order on Friday, “We deem it appropriate to direct the State Government to ensure that Ration material/Food packets be made available to all the needy Pakistani Minority Migrants residing in various districts of Rajasthan either through the Food Supplies Department/Local Bodies or NGOs/Social Institutions".

The counsel for the state government during the hearing submitted that the SOP dated May 6 issued by the central government is silent regarding the Pakistani minority migrants and, therefore it's important that the clarifications are being sought from the central government regarding the vaccination of Pakistani minority migrants, who have not been given the citizenship so far.

The court observed on Friday that the SOP on COVID-19 vaccination of persons without prescribed identity cards issued by the central government in no way excludes Pakistani migrants.

The state government on Friday told HC that around 25,000 (Pakistani Minority Migrants are at present residing in various districts of Rajasthan including around 7,500 in Jodhpur.

“We are of the opinion that the SOP on COVID-19 vaccination of persons without prescribed identity cards through CoWIN issued by the Central Government is elaborate and in no way excluding the Pakistani Minority Migrants who are eligible for COVID-19 vaccination,” the court said in its order.

While hearing a suo moto petition about the struggles of Pakistani migrants during the Covid-19 pandemic, the court observed, “We are of the opinion that the SOP on COVID-19 vaccination of persons without prescribed identity cards through CoWIN issued by the Central Government is elaborate and in no way excluding the Pakistani Minority Migrants who are eligible for COVID-19 vaccination,” the court said in its order.

“The second submission on behalf of the Pakistani Minority Migrants is this that in the absence of Aadhar Card and other documents, the eligible Pakistani Minority Migrants are deprived of COVID-19 vaccination, which is very essential for every human being,” the court order states further.

A day earlier the court while hearing the issue pertaining to vaccination of Pakistani Hindu migrants had directed the state government to inform it about the steps taken by the administration regarding vaccination of those migrants who are not having the requisite identity cards. The court has also asked the state government to release a report about the availability of ration to the refugees living in the various settlements in Jodhpur.

The court order observed that non-availability of ration to the Pakistani migrants is a serious matter."The order reads, "Due to the strict lockdown imposed by the state government, in wake of Covid second wave, the Pakistani Migrants staying in various settlements in Jodhpur are struggling to fulfil their basic needs like food, water and medical health facility".

The court on Friday asked the state government to submit a detailed report regarding the compliance with the guidelines given in the Centre’s May 6 SOP.

Outlook had reported on the struggles faced by Pakistani Hindus in Jodhpur. Activists working for the rights of Pakistani Hindu migrants in Rajasthan hailed the decision of the Rajasthan high court. Hindu Singh Sodha, president of the Seemant Lok Sangathan told Outlook, "The directions of them should be taken seriously the district administration. The covid has created a scare in the settlements especially after a few succumbed to this de=readful disease. They are facing the worst. We had written a series of letters to Prime Minister Narendra Modi and Rajasthan Chief Minister Ashok Gehlot, demanding the intervention in the matter and assuring vaccination drive for the migrants back in April. In one of the guidelines of the central government on the vaccination, there is a provision for beggars, homeless, nomadic tribes etc who do not have an Aadhar card but there is no provision for refugees who have come to our country to seek safe shelter".

In Rajasthan, after Jaipur, Jodhpur has the second-highest number of Covid cases. The district has so far witnessed 1, 10,598 cases and 1,039 deaths. It has around 5,500 active Covid positive cases, as per the daily health bulletin.

As per the activists, around 70 per cent do not have an Aadhar card which makes them ineligible for the vaccination as per the norms of the central government

On May 13, the Seemant Lok Sangathan, which has been working for the rights of Pakistani Hindu migrants for more than three decades moved an application at Rajasthan High Court.
 
most of those are bottom tier vaccines except mayb sputnik V and they're not trusted by the FDA, India is screwed unless they're able to get Pfizer or Moderna and that isn't happening until next year

That's your opinion. You are neither an expert nor a doctor. Unless and until you back up your opinion with credible source, its nothing but a pakistanis green tinted biased and jealous view, which in reality will change nothing.


Pfizer has offered to sell India 50mn doses this year.

What vaccines are pakistan getting? And how many?
 
That's your opinion. You are neither an expert nor a doctor. Unless and until you back up your opinion with credible source, its nothing but a pakistanis green tinted biased and jealous view, which in reality will change nothing.


Pfizer has offered to sell India 50mn doses this year.

What vaccines are pakistan getting? And how many?


Read the title of this thread.
 
India needs to get Pfizer or Moderna. Even those who are getting AstraZenica shots are dying left, right and centre, I doubt it is a good vaccine. Less said the better about India's own 'vaccine', Covaxin.
 
India needs to get Pfizer or Moderna. Even those who are getting AstraZenica shots are dying left, right and centre, I doubt it is a good vaccine. Less said the better about India's own 'vaccine', Covaxin.

Aztrazeneca has been widely used around the world, including UK. Studies done in UK suggest that AZ is effective against all variants, except may be B1351.

What do you know about Covaxin that you are passing this judgement? Any reasons?
 
It hasn't even been approved by World Health Organisation, unlike other major vaccines available.

WHO has approved Chinese Sinopharm. What does that tell you? Has any reputed peer reviewed journal reviewed the Sinopharm vaccine?

Covaxin only recently applied for the WHO approval.
 
India just needs to vaccinate its population, whether covishield or covaxin. The commonly held medical opinion is forget about which vaccine, if a vaccine is available, take it, unless it has major side effects.

A person being vaccinated with either covishield or covaxin is far better than being unvaccinated and waiting for Pfizer or Moderna or whatever vaccine, which is foolish to say the least. Just vaccinate your population, everything else about the brand of vaccines comes across as sour grapes to me.
 
That tells me China has provided all the necessary trial data to the WHO. Sinopharm has already been peer reviewed.
https://www.bloomberg.com/news/arti...publishes-awaited-covid-vaccine-study-details

I can only assume Covaxin hasn't applied for WHO approval yet because of its pathetic third phase trial data.

That tells you how deep the WHO is in the chinese pocket. The non medico politician from the communist party of Ghana is one of the reasons for the spread of this pandemic.

Anyways, from the article you posted.

The testing was heavily skewed toward men, who accounted for nearly 85% of the participants. Less than 2% were aged 60 or older, and most were healthy. As a result, there is little evidence about the efficacy and safety among women, the elderly and those with underlying diseases.


The trials have big limitations. Covid affects elderly and thosr with comorbidities more severely. Sinopharm hardly had any volunteers from that group.

Unlike Sinopharm, which delayed its trial publications, Covaxin has published its phase 1 and 2 as well as the intermediate phase 3 results.
 
New Delhi: Delhi Deputy Chief Minister Manish Sisodia said on Saturday accused the Centre of "sitting on" the vaccine distribution system and asked how private hospitals were getting vaccines.

Alleging "mismanagement" by the Central government, he sought to know as to why states were being told that there is a shortage of stocks while private hospitals were getting vaccines.

Sisodia further said that Delhi needs 1.84 crore COVID-19 vaccine doses to inoculate 92 lakh people in the age group between 18 to 44 but the Centre has provided only 4.5 lakh doses in April and 3.67 lakh doses in May.

"The Centre has informed us that a limited stock of 5.5 lakh doses will be provided in June, but not before June 10," he said.

The deputy CM said that the shortage of vaccine doses has forced the Delhi government to shut inoculation centres for the 18-44 age group, urging the Centre to share the data on doses provided to the states and the private sector.

He also that he had raised the demand of zero GST on COVID-19 vaccines, oxygen cylinders, concentrators, ventilators and other equipment used in the treatment of the viral disease during Friday's GST Council meeting.

Meanwhile, Delhi on Saturday logged 956 new cases of COVID-19 in the last 24 hours, the lowest in over two months. This is the first time since March 22, when 888 infections were recorded, that daily cases in Delhi have dropped below 1,000.

Chief Minister Arvind Kejriwal stressed that if new infections continue to decline, more activities will be allowed to open up in the city.

The phase-wise process of easing the lockdown restrictions in the capital will begin from Monday, starting with the resumption of construction activities and the reopening of factories for a week.
 
Ramdev again questions Covid-19 vaccines, says he’s protected by yoga & Ayurveda

Ram Dev had earlier raised 25 questions on the efficacy of modern medicine and the IMA Uttarakhand chapter threatened him with a ₹1000 crore defamation case and Delhi Medical Association filed a police complaint against the yoga guru.

Yoga guru Swami Ramdev has again questioned the efficacy of Covid-19 vaccines while claiming that the fatalities caused by Covid-19 showed that allopathy was not 100% effective. He also alleged the presence of a campaign against ancient Indian science of Ayurveda. The Yoga guru who has been in a running feud with the Indian Medical Association (IMA) also claimed that he didn’t opt for vaccination since he has been enjoying the dual protection of yoga and Ayurveda for several years now.

“For decades, I have been practicing yoga-Ayurveda doses so I didn’t feel the need to get vaccinated. Over 100 crore people of India as well as in foreign countries are in reach of these ancient therapies. In the coming time, Ayurveda will be globally accepted. A section of society is deliberately ignoring or deeming it inferior in comparison to allopathy,” said Swami Ramdev.

Ram Dev had earlier raised 25 questions on the efficacy of modern medicine and the IMA Uttarakhand chapter threatened him with a ₹1000 crore defamation case and Delhi Medical Association filed a police complaint against the yoga guru. It all started a couple of weeks ago with a video, where Ramdev was seen calling allopathy a ‘stupid science’ and alleging that thousands of doctors had died despite taking the vaccine to prevent Covid-19 infection. He later retracted those comments following the IMA and Union health minister’s objection

https://www.hindustantimes.com/india-news/ramdev-again-questions-covid-19-vaccines-says-he-s-protected-by-yoga-ayurveda-101622376819966.html
 
Haryana's ML Khattar Says Arvind Kejriwal Gives Out Vaccines 'Too Fast'

New Delhi: Delhi Chief Minister Arvind Kejriwal, who has been red-flagging the shortage of vaccines in the national capital over the last few weeks, has been accused of "indulging into politics" by the BJP's ML Khattar, his Haryana counterpart. "My goal is to save lives, not vaccines," Mr Kejriwal tweeted today in a sharp response to ML Khattar.
Mr Khattar in a televised briefing on Sunday was apparently referring to the Delhi government's decision about a week ago to pause vaccination for the 18-44 age group and temporarily shut vaccine centres.

"It was just drama when he said 'all vaccine centres will be shut from tomorrow because we are not getting doses'. I believe Delhi's share is much larger than other states."

"Like other states, should we also finish all 2 lakh doses in a day? We use 50,000-60,000 doses a day. All this... Arvind Kejriwal should see. But his intention is to indulge in politics and he does that. Nobody should play politics during a pandemic," the BJP leader further said, suggesting that Delhi was giving out vaccines "too fast".

https://www.ndtv.com/india-news/cor...ot-vaccines-2452937?pfrom=home-ndtv_topscroll
 
Kahan se aate hain yeh clowns?

I mean, seriously is there anything wrong with vaccinating people too fast during this catastrophe? Just because this Khattar clown is bloody incompetent himself, he wants others to follow suit too.

Amazing, really amazing! Kind of clowns we have elected to rule us!
 
Will 'Convert' 1,000 Allopathic Doctors To Ayurveda: Claims Ramdev Amid Controversy


Baba Ramdev said during a yoga session that he has a target of converting 1,000 allopathic doctors to Ayurveda in a year's time


Ramdev was addressing participants who had gathered from across the country
He said several allopaths holding MBBS and MD degrees were also attending the yoga camp
As the controversy over his comments against allopathic medicines and doctors is drawing severe ire, yoga guru Baba Ramdev said during a yoga session that he has a target of converting 1,000 allopathic doctors to Ayurveda in a year's time.

Ramdev was addressing participants who had gathered from across the country. He said several allopaths holding MBBS and MD degrees were also attending the yoga camp.

“These are the doctors who have faced the side-effects of allopathic drugs and have now turned to yoga and Ayurveda. Some of them have taken voluntary retirement from their practice and decided to follow our path."

"In fact, I have decided that in the next one year, our target would be to convert over 1,000 allopathic doctors to naturopathy," said Ramdev.

Doctors to protest Ramdev's remarks
The Federation of Resident Doctors' Association (FORDA) India will hold a nationwide protest against Yoga Guru Ramdev on June 1 over his statements regarding allopathic doctors and modern medicine.

FORDA India said they will hold a nationwide black day protest "without hampering the patient care to voice their protest against the statements of Yoga Guru Ramdev against COVID warriors and modern medicine."

The association also demanded an unconditional open public apology or action against him under the Epidemic Diseases Act.

On Wednesday, the Indian Medical Association (IMA) had appealed to Prime Minister Narendra Modi to take appropriate action under sedition and other charges against Ramdev for allegedly "spearheading a misinformation campaign on COVID vaccination".

The IMA had sent a legal notice to yoga guru Baba Ramdev over his alleged statements against allopathy and "defaming" scientific medicine.

https://www.indiatimes.com/news/india/will-convert-1000-allopathic-doctors-to-ayurveda-claims-ramdev-amid-controversy-541594.html
 
At 3 Million Doses, Biggest Tranche Of Sputnik V Vaccines Lands In India

The vaccine consignment arrived from Russia on a specially chartered freighter RU-9450 which touched down at Hyderabad Airport at 3:43 am.

New Delhi/Hyderabad: The biggest tranche yet of Russia's Sputnik V vaccine arrived in Hyderabad before dawn today and was cleared in a record 90 minutes. At 3 million doses, weighing 56.6 tonnes, this is the biggest import consignment of COVID-19 vaccines to arrive in the country.
The vaccines arrived from Russia on a specially chartered freighter RU-9450, which touched down at Hyderabad Airport at 3:43 am.

The Sputnik V vaccine requires specialised handling and storage; it has to be kept at -20 degrees Celsius, read a statement from GMR Hyderabad Air Cargo, which has emerged as the air cargo hub for vaccine imports into India.

GMR Hyderabad says it has been working closely with experts from the vaccine supply chain team, customs officials and other relevant stakeholders to ensure that the necessary infrastructure and handling processes are fully in place at the terminal for smooth handling of the vaccine shipments.

Sputnik V is the third vaccine to be cleared for use in India after Serum Institute of India's Covishield and Bharat Biotech's Covaxin.

With India's vaccination drive hamstrung by vaccine shortages, various states have been sending SOS to centre for quick release of doses.

Sputnik V, named after the first Soviet Space satellite, works on the principle of a weakened Covid virus delivering parts of a pathogen that triggers an immune response in the body.

The Apollo Group of Hospitals has announced that it will start administering Sputnik V across its hospitals in India from the second week of June at an estimated price of ₹ 1,195 per dose.

Sputnik V was registered in India under emergency use authorization procedure on April 12.

On Monday the Supreme Court flagged "various flaws", including discrepancy in supply and costs for different groups in centre's vaccination policy.

The centre has said it plans to vaccinate all of India by the end of 2021. Last month it pointed to a blueprint that said over 200 crore doses will be available between August and December.

Warning against a possible third wave, experts have said it is imperative to vaccinate as much of the population, as quickly as possible, to minimise the impact of any future waves.

India today reported 1.27 lakh new infections - lowest daily rise since April 9 - taking the overall Covid case count to 2.81 crore. It also logged 2,975 deaths. The country is now witnessing a drop in cases amid a battle against the second Covid wave

https://www.ndtv.com/india-news/at-3-million-doses-biggest-tranche-of-sputnik-v-vaccines-lands-in-india-2453619
 
New Delhi: The Centre is likely to give indemnity against legal proceedings to foreign coronavirus vaccine manufacturers Pfizer and Moderna along the lines of what has been granted in other countries to the companies, sources in the government said on Wednesday.

Health Ministry sources suggested that the indemnity against liability as requested by vaccine manufacturers Pfizer and Moderna in India should not be an issue and that it will be given to them (as it has been granted in other countries including the United States) provided these companies apply for Emergency Use Authorisation in India.

As per reports, Cipla had requested indemnity and a number of exemptions relating to bridging trials and customs duties for Pfizer. Like Moderna, Pfizer has also insisted on indemnity just like it has sought in every country it has supplied vaccines to.

It is important to note that the central government, so far, has refused to provide indemnity to any vaccine manufacturer.

Cipla, on Tuesday, said that it was nearing committing over Rs one billion as an advance to Moderna, as it seeks to procure five crore doses for 2022. Pfizer has already stated that it was willing to offer five crore doses to India between July and October this year.

DCGI waiver likely to bring foreign vaccines like Pfizer, Moderna a step closer
Meanwhile, the Drugs Controller General of India (DCGI) has done away with specific trials of COVID-19 vaccines that have received approvals by other international regulatory bodies - a big move likely to clear the way for foreign vaccines for the country's urgent requirement.

DGGI chief VG Somani said that this will be applicable for vaccines that have already been approved for restricted use by the US FDA, EMA, UK MHRA, PMDA Japan or listed for Emergency Use by the World Health Organization.

https://www.timesnownews.com/india/...-proceedings-to-pfizer-moderna-sources/765099
 
Thousands of doctors across India are putting on black armbands and calling for the arrest of a hugely popular guru who has claimed yoga can prevent COVID-19 and that conventional medicine has killed thousands of coronavirus patients.

Baba Ramdev, the creator of a successful traditional medicine empire, said last month the pandemic showed modern pharmaceuticals to be “stupid and failed science” and claimed hundreds of thousands “have died because they had allopathy (conventional) medicines”.

On Tuesday’s “Black Day” of protests, photos on social media showed doctors with banners demanding the arrest of “Quack Ramdev” while others wore PPE suits with #ArrestRamdev written on the back.

The doctors’ association at the All India Institute of Medical Sciences (AIIMS), one of Delhi’s biggest government hospitals, called Ramdev’s comments “disgraceful”.

Doctors also changed their social media profile pictures to black squares, Al Jazeera’s Elizabeth Puranam said, reporting from capital New Delhi.

“In a country like India where people tend to follow spiritual gurus, yoga gurus and that too blindly, when people like that, they spread mistrust, misinformation, it becomes very difficult for us as science-based people, as doctors to wipe that misinformation out,” Dr Mehak Bhushan of the Federation of Resident Doctors Association told Al Jazeera.

Ramdev, a keen supporter of Prime Minister Narendra Modi, retracted his comments after an appeal by India’s Health Minister Harsh Vardhan and the guru said he had been merely reading out other people’s WhatsApp messages.

But he then caused a further outcry by saying that he did not need a coronavirus vaccine because he was protected by yoga and traditional medicine, or Ayurveda.

Ramdev’s company Patanjali Ayurved is worth hundreds of millions of dollars, selling everything from toothpaste to jeans at its ubiquitous stores.

Earlier this year, it launched a herbal remedy called Coronil that Ramdev, who also has a TV channel, said would cure coronavirus.
The launch event was attended by Vardhan, himself an allopathic doctor and chair of the executive board of the World Health Organization (WHO).

Doctors say Ramdev is “taking advantage of the pandemic and his large public following to persuade people to buy his unapproved products”, Puranam reported.

Ramdev had claimed Coronil was approved by the WHO, but the global health body denies the claim.

A senior journalist who had his car tyres slashed while investigating Ramdev’s business interests says the yoga guru is protected by Modi’s right-wing government.

“His vested interest in businesses, which is really what he is behind the sham of being a yogi… it has been documented to some extent… So in some sense, he has a political sanction and therefore has a large degree of impunity in getting away with what he does,” Nitin Sethi told Al Jazeera.

Patanjali – which ranks 13th in India’s trusted brand rankings published last year – has previously claimed it had cancer remedies, while Ramdev has also said he can “cure” homosexuality and AIDS.

Ramdev’s spokesperson did not respond to Al Jazeera’s request for an interview.

But the yoga guru counts millions of Indians as followers, including Anil Sabharwal who sells his range of products.

“I don’t sell Patanjali products just for business. This is a matter of faith. Guru Ramdev shows us the way,” shop owner Anil Sabharwal told Al Jazeera.

“I had some ailments, but the moment I started hearing his sermons, the healing process had already begun.”

Many people in India have a deep trust in gurus and alternative medicine. But doctors say Ramdev’s claims cannot be substantiated, and he must be held to account for his statements, especially during a pandemic.

Coronavirus has left at least 330,000 people dead in India, including more than 1,200 doctors, according to the Indian Medical Association.

Al Jazeera
 
India's Supreme Court has sharply criticised the federal government over its coronavirus vaccination programme.

The judges asked the government to explain why it was mandatory to register on an app for getting a jab.

The court said this would hamper vaccinations across rural India where internet access is difficult.

The judges also questioned whether federal policy was making individual states compete against each other for vaccines.


India has administered more than 220 million doses since it began vaccinating in mid-January, but so far only 3% of the population has been fully vaccinated.

Prime Minister Narendra Modi's government has opened up vaccinations for some 960 million eligible Indians without having anything close to the required supply.

The shortage came amid a deadly second Covid wave and warnings of an impending third wave. The wave has since slowed - the number of daily infections has fallen from the peak of over 400,000 last month to 132,788 cases that were recorded in the past 24 hours.

The Supreme Court said that asking people between 18-44 years to pay for their jabs was "arbitrary and irrational".

The court asked the government to review its vaccination policy and "place on record a roadmap of projected availability of vaccines till 31 December" - the date by which the government is promising to vaccinate the entire adult population.

India says it aims to ramp up vaccine production and has pledged to produce at least two billion doses between August and December.

There are currently two locally-made vaccines for the coronavirus: Covishield and Covaxin.

The Serum Institute of India (SII) makes Covishield (under licence from AstraZeneca), whilst the second largest producer, Bharat Biotech, makes the locally-developed Covaxin.

The Sputnik V vaccine, which was approved for use in April, is also now available, with three million doses supplied by Russia.

Of the eight vaccines currently under production in India, only three have been approved for use - another two are in the early stages of clinical trials and a further three are in late-stage trials.

Public health experts say poor planning, piecemeal procuring and unregulated pricing by the government has turned India's vaccine drive into a deeply unfair competition for state governments.

BBC
 
Someone From Russia Found Vaccine Maker In Himachal, Centre Failed: High Court

New Delhi: The Delhi High Court on Friday expressed anguish over the way things have transpired in the second wave of COVID-19 where vaccine shortage is hitting everyone even when the Central government says the best way to fight the pandemic is to vaccinate the entire population.

The high court was deliberating with the issue related to manufacturing of COVID-19 vaccine Sputnik V by India's Panacea Biotec in collaboration with Russian Direct Investment Fund (RDIF).

The high court directed the Centre to release arbitral award of over ₹ 14 crore along with interest from 2012 to Panacea Biotec for manufacturing Sputnik V vaccine in India subject to the condition that the company obtains permission from the government to manufacture the vaccine.

A bench of Justices Manmohan and Najmi Waziri said the release of the amount, awarded to the company by the arbitral tribunal, will also be subject to the undertaking of the firm that 20 per cent of its sale proceeds of Sputnik V will be deposited with the court's registry till the awarded amount is secured.

"Today, we are a bit anguished with the way things have transpired during the second wave. As a responsible citizen you also would be anguished. Vaccine shortage is hitting each and everyone. Even today vaccine is not available in Delhi. You have good products in India, a little handholding will work," the bench said.

It added that "Someone from Russia was able to locate infrastructure in Himachal Pradesh but the Centre has failed to do so."

The high court's order came on a plea of Delhi-based Panacea Biotec seeking to modify a July 2020 order, by which the firm had undertaken not to prosecute further the execution proceedings instituted by them in relation to an arbitral award, running into crores of rupees, passed in its favour and against the Centre.

https://www.ndtv.com/india-news/som...-high-court-2456593?pfrom=home-ndtv_topscroll
 
Last edited:
US lawmakers push Biden for more Covid-19 vaccines and medical aid to India

The American lawmakers called on the US government to send more vaccines and medical assistance to India after President Joe Biden on Thursday announced that the US will allocate 75 per cent - nearly 1.9 crore of the first tranche of 2.5 crore doses - of unused Covid-19 vaccines from its stockpile to countries in South and Southeast Asia as well as Africa by the end of June.

Several US lawmakers have urged the Biden administration to ensure that India receives enough Covid-19 vaccines and medical aid, saying the health crisis in the country is "devastating" and America has a responsibility to help its close allies defeat the pandemic.

The American lawmakers called on the US government to send more vaccines and medical assistance to India after President Joe Biden on Thursday announced that the US will allocate 75 per cent - nearly 1.9 crore of the first tranche of 2.5 crore doses - of unused Covid-19 vaccines from its stockpile to countries in South and Southeast Asia as well as Africa by the end of June.

Biden said the US will share the vaccine to many countries to fight the pandemic through the UN-backed COVAX global vaccine sharing programme as part of his administration’s framework for sharing 80 million (8 crore) vaccines globally.

"The crisis in India is devastating and demands more action from (President Joe) Biden. More Covid-19 vaccines and medical supplies are needed to help one of our most important global allies fight this virus," Texas Governor Greg Abbott said.

Read complete article here : https://www.hindustantimes.com/world-news/us-lawmakers-push-biden-for-more-covid-19-vaccines-and-medical-aid-to-india-101623046785943.html
 
Major Indian states that have been virus hotpots are easing restrictions as Covid case numbers continue to fall.

National capital Delhi and financial hub, Mumbai, are among the cities that are opening partially.

This comes in the wake of a crushing second wave that saw hospital beds, medicines and even oxygen run short as cases spiked and deaths rose.

But experts continue to advice precaution amid a lagging vaccine drive and the threat posed by new variants.

India has administered more than 230 million jabs of a Covid vaccine so far - but less than four percent of it's 1.4 billion people have been fully vaccinated.

It has also struggled to speed up the drive across the country, partly because of a botched roll-out that saw demand outstrip supply.

Among other things, it allowed higher prices for jabs in private hospitals, which has skewed access heavily in favour urban areas and those who can afford to pay. Vaccine hesitancy too remains a challenge, especially in rural areas.

India reported about 101,000 new infections on Monday and more than 2,400 deaths - far lower than the nearly 400,000 daily cases it was recording about a month ago. It has registered some 28 million cases and 349,000 deaths so far, but experts say the actual toll is far higher.

BBC
 
Get Vaccinated, Get 20 Kg Rice In Arunachal: Offers States Are Making To Boost Vaccine Drive

The states across India are leaving no stones unturned Rice and that too, 20 kg in return of getting jabbed? The prospect turned out to be lucrative enough to dispel rumours around vaccination among villagers of an administrative circle in Arunachal Pradesh, as over 80 of them turned up on foot for the inoculation within days of the announcement of the offer.

Vaccination
The brainchild of Circle Officer Tashi Wangchuk Thongdok of Yazali in Lower Subansiri district, the offer of free rice for those getting vaccinated in the 45-plus age group was launched on Monday and is valid till Wednesday. “We are constantly trying to work out strategies to improve vaccination coverage in the circle and in the district.

“Till today noon, 80 people have come to receive the jabs. Our aim is to achieve 100 per cent inoculation in the circle by June 20," Thongdok, a 2016-batch APCS officer, said. There are 1,399 people above the age of 45 in the Yazali Circle, officials said.

Many of those who came to get themselves vaccinated came on foot from far-flung villages, braving inclement weather, Thongdok said. He said the administration is chalking out a roadmap for taking the vaccination drive to every village of the circle.

1. Uttar Pradesh
In Uttar Pradesh's Firozabad the government employees will not receive their salaries unless and until they are vaccinated for COVID-19. The main idea behind this is to encourage people to take the COVID-19 vaccine.

On Wednesday the Chief Development Officer, Charchit Gaur said that District Magistrate Chandra Vijay Singh has issued an oral order of 'no vaccination, no salary'.

As per the order, if any employee refuses to take the COVID-19 vaccine, the department will initiate action with the district administration and stop their salary for the month of May, Gaur said.

2. Madhya Pradesh
Astern decision that those not going for vaccination would be deprived of ration offered from public distribution shops (PDS) in MP’s Gram Panchayat in Jabalpur has done wonders as the village has now reached 85% vaccination.

The order was issued by Sihoda panchayat under Shahpura block of Jabalpur after large numbers of locals remained disinterested for vaccination. The Gram Panchayat around 30km from Jabalpur town issued a diktat that those not vaccinated won’t be offered ration.

Not only this, locals were told by the rural body that for availing benefit of any government scheme, one has to get vaccine jabs. This fuelled a kind of frenzy among locals as in no time the village of around 1,200 achieved 85% vaccination.

3. Karnataka
Similarly, in Karnataka, in a bid to counter vaccine hesitancy and to prod residents residents to get inoculated against Covid-19 on priority, Gadak gram panchayat has passed a “no vaccine no ration” resolution.

Officials of the Kotabal gram panchayat said they are aware that PDS supplies cannot be stopped on such grounds and that it is merely a slogan to motivate villagers.

https://www.indiatimes.com/news/india/get-vaccinated-get-20-kg-rice-in-arunachal-offers-states-are-making-to-boost-vaccine-drive-542519.html
 
Last edited:
India starts to reopen as cases hit two-month low

Shops and malls have been allowed to reopen in Delhi.

Experts have cautioned against a full re-opening as India has vaccinated only about 5% of its estimated 950 million adults with the necessary two doses, leaving millions vulnerable.

Infections peaked in India in May with about 400,000 new cases a day but that dropped to 70,421 new infections reported on Monday, the lowest daily increase since 31 March, health ministry data showed.

Authorities in Delhi allowed all shops to re-open although bars, gyms, salons, cinemas and parks remained shut.

Religious places have also been allowed to reopen in the city but no devotees are allowed inside.

The pressure to resume some economic activity has grown as millions depend on daily wages to pay for food and rent.
 
AIIMS Delhi to begin screening children between 6 and 12 yrs for Covaxin trials

“The selection process for the clinical trial of Covaxin among children in the age group of 6-12 years will begin from Tuesday,” Dr Sanjay Rai, professor at the Centre for Community Medicine at Aiims Delhi, told news agency PTI on Monday.


The All India Institute of Medical Sciences (Aiims), New Delhi will on Tuesday begin screening children in the age group of 6-12 years for the clinical trials of Bharat Biotech’s Covaxin. “The selection process for the clinical trial of Covaxin among children in the age group of 6-12 years will begin from Tuesday,” Dr Sanjay Rai, professor at the Centre for Community Medicine at Aiims Delhi, told news agency PTI on Monday.

The selection for clinical trials in the 12-18 years is already over and children within this age group have been administered with a single dose of the vaccine. Once the recruitment of children from 6-12 years is done, Aiims New Delhi will begin trials for children between 2 and 6 years.

Prior to Delhi, Aiims Patna started paediatric trials for Covaxin on 12-18 years from June 3.

“After these trials, the age group will be 6-12 years and then 2-6 years but now we have started trials in the age group of 12-18 years,” Dr Prabhat Kumar Singh, director of Aiims Patna said last week adding 54 children had registered for the trials of which 16 belonged to the 12-18 years age group.

https://www.hindustantimes.com/india-news/aiimsdelhi-to-begin-screening-children-between-6-and-12-yrs-for-covaxin-trials-101623666434053.html
 
https://www.reuters.com/world/india/exclusive-indian-scientists-we-didnt-back-doubling-vaccine-dosing-gap-2021-06-15/

The Indian government doubled the gap between the two doses of the AstraZeneca COVID-19 vaccine without the agreement of the scientific group that it said recommended the increase, three members of the advisory body told Reuters.

The ministry of health announced the decision to change the gap from 6-8 weeks to 12-16 weeks on May 13, at a time when supplies of the shot were falling short of demand and infections were surging across the country.

It said the extended gap was recommended by the National Technical Advisory Group on Immunisation (NTAGI), based on real-life evidence mainly from Britain. Yet the NTAGI scientists, classified by the government as three of the 14 "core members", said the body did not have enough data to make such a recommendation.

M.D. Gupte, a former director of the state-run National Institute of Epidemiology, said the NTAGI had backed increasing the dosing interval to 8-12 weeks - the gap advised by the World Health Organization. But he added that the group had no data concerning the effects of a gap beyond 12 weeks.

"Eight to 12 weeks is something we all accepted, 12 to 16 weeks is something the government has come out with," he added. "This may be alright, may not be. We have no information on that."

This was echoed by his NTAGI colleague Mathew Varghese, who said the group's recommendation was only for 8-12 weeks.

The health ministry, citing the head of NTAGI's working group on COVID-19, said that the dosing decision was based on scientific evidence. "There was no dissenting voices among the NTAGI members," the ministry said on Twitter.

The ministry's statement on May 13 said that it had accepted the 12-16 weeks recommendation from NTAGI's COVID working group, as had a group of mainly government officials tasked with vaccine administration, known as NEGVAC.

Government health officials told a news conference on May 15 the gap was not increased to address a vaccine shortage but was a "scientific decision".

J.P. Muliyil, a member of the seven-strong COVID working group, said there had been discussions within the NTAGI on increasing the vaccine dosage interval but that the body had not recommended 12-16 weeks.

"That specific number was not quoted," he said, without elaborating.

N.K. Arora, the COVID working group head, declined to comment to Reuters on its recommendations but said all its decisions were taken collectively by the NTAGI at large.

A NEGVAC representative said it "respects the decisions of the NTAGI and use them for our work", declining to elaborate.

Real-world data released early last month by South Korea showed that one dose of the vaccines from AstraZeneca and Pfizer was 86.6% effective in preventing infections among people aged 60 and older.

Muliyil said this increased confidence within the advisory body that delaying a second shot would not be harmful.

The AstraZeneca vaccine accounts for nearly 90% of the 257.5 million vaccine doses administered in India.

The dispute over doses comes amid criticism from some scientists that the government had been slow to respond to a new virus variant that led to a spike in infections in April and May.

The government has denied being slow to react, saying state-run laboratories had studied variants in real time and shared data with local authorities to allow them to take the necessary action.

Shahid Jameel, a top Indian virologist who recently quit a government panel on virus variants after criticising New Delhi over its response to the pandemic, said the authorities should clarify their position on the reasons for the decision to double the gap between doses.

“In a situation where we have a variant of concern spreading, we should really be vaccinating people at scale and making sure that they are protected,” he added.
 
Fake coronavirus tests may have helped fuel Indian outbreaks.

The Indian authorities launched an investigation after an internal government report concluded that some private agencies responsible for coronavirus testing on pilgrims at a sprawling Hindu festival forged at least 100,000 results.

The festival, Kumbh Mela, which ran throughout April, is widely believed to be responsible for a coronavirus surge in many parts of India, as the pilgrims returning from the festival tested positive days after returning to their villages. The festival drew millions of faithful to the town of Haridwar on the banks of the river Ganges in the northern state of Uttarakhand.

“We have constituted a four-members committee that will submit its report in two weeks,” Dr. Arjun Singh Sengar, a Haridwar health officer who was in charge of testing for Kumbh Mela, said in an interview. “Initial investigations are pointing toward lapses and fake results.” Dr. Sengar said that out of 251,000 tests in his district, only 2,273 were positive.

But health experts questioned those numbers, saying the state government underreported positive cases. That suggested it was safe to take part in the pilgrimage, despite evidence that the largely unmasked crowds provided an ideal environment for the virus to spread.

According to a sprawling government report on the lab that conducted rapid antigen tests during the festival, at least 100,000 test results out of 400,000 were fake.

Despite warnings by public health experts and doctors, the regional government led by Prime Minister Narendra Modi’s party advertised the festival in newspapers, inviting pilgrims from across the country.

Before the event, Uttarakhand’s top elected official, Tirath Singh Rawat, mingled with huge crowds of pilgrims, without a mask. When questioned during one of his three visits to the holy site, Mr. Rawat said, “Faith in God will overcome the fear of the virus.” He tested positive for the coronavirus two days after his last visit to the Ganges.

Officials in Uttarakhand began investigating the test results after a man in the neighboring state of Punjab received a negative test from the health department in Uttarakhand, even though he had not visited the state. He filed a complaint with the Indian Council of Medical Research, a top government body. Officials alerted the state government, which is now leading the investigation and has stopped payments to dozens of private laboratories and agencies involved in testing.

Testing scams have been a persistent problem in India. Some, according to a report by the state, have simply filled log books with fake names and addresses, then charged the state government for the service. In Haridwar, the report found that some sample collectors listed for the festival had never even visited the town.

The authorities said they found phone numbers used multiple times to register pilgrims who were tested, and private agencies carrying out the tests wrote fictional addresses for people who were supposedly tested on their arrival for a dip in the holy waters. When officials called the numbers in the logs, they found they were false.

NYT
 
Need quick, complete inoculation, not BJP’s lies: Rahul Gandhi on Centre 'extending' Covishield dose gap

Rahul Gandhi, who has been the most vocal critic of the Centre’s response to the pandemic, has time and again criticised it over its vaccination policy. On May 28, he said vaccination is the only permanent solution to combat Covid-19 and only a minuscule percentage of the country’s population was inoculated.

Congress leader Rahul Gandhi on Wednesday targeted the central government over extending the gap between two doses of AstraZeneca’s vaccine against the coronavirus disease (Covid-19). In India, the vaccine is named as Covishield and is produced by the Pune-based Serum Institute of India (SII).

Rahul Gandhi, who has been the most vocal critic of the Centre’s response to the pandemic, has time and again criticised it over its vaccination policy. On May 28, he said vaccination is the only permanent solution to combat Covid-19 and only a minuscule percentage of the country’s population was inoculated. He also pointed out that if vaccination continues at the present pace, the entire population will be only inoculated by 2024.

Citing a report from news agency Reuters on his Twitter handle, Gandhi said on Wednesday the country needs quick and complete vaccination against the viral disease and not the Bharatiya Janata Party’s (BJP) usual brand of lies and rhyming slogans to cover up the vaccine shortage caused by Prime Minister Narendra Modi-led central government. “GOI’s constant attempts to save the PM's fake image are facilitating the virus & costing people’s lives,” Gandhi added.

https://www.hindustantimes.com/india-news/rahul-gandhi-hits-out-at-centre-over-prolonged-gap-between-covishield-doses-101623839222394.html
 
https://www.reuters.com/world/india/opposition-questions-india-govt-doubling-vaccine-dosing-gap-2021-06-16/

India’s government on Wednesday defended its decision to double the gap between the two doses of the AstraZeneca COVID-19 vaccine to up to 16 weeks, after three scientific advisers said there was no agreement on such a wide interval.

Reuters reported on Tuesday that the government increased the gap last month without the approval of the scientific group that it said recommended the move, citing three members of the National Technical Advisory Group on Immunisation (NTAGI) advisory body.

In multiple statements on Wednesday, the government said the interval was increased based on scientific evidence after thorough discussions among members of NTAGI as well as its working group on COVID-19 in two meetings held in May.

The AstraZeneca shot, made locally and branded Covishield, accounts for nearly 90% of the 259 million doses administered in India, where some states have curtailed vaccination programmes over supply constraints.

The government said a NTAGI working group on May 10 initially recommended increasing the dosing interval to 12-16 weeks, a proposal that was subsequently taken up by a larger NTAGI committee on May 13. The committee advised that "as per the COVID-19 working group recommendation, a dosing interval of a minimum three months between two doses of Covishield vaccine was recommended", the government said in a statement.

According to the minutes of an NTAGI meeting held on May 28, the interval was increased based on real-world data from Britain that showed 65% to 88% protection after the first dose, if the gap was up to 12 weeks.

"Therefore, based on the real-world evidence, dose intervals between two doses of Covishield was increased from 4-8 weeks to 12-16 weeks," said the minutes published on the health ministry's website.

J.P. Muliyil, a member of the COVID working group, had told Reuters on Tuesday there had been discussions within the NTAGI on increasing the vaccine dosage interval but that the body had not specifically recommended 12-16 weeks.

NTAGI members had told Reuters that the group had no data concerning the effects of a gap beyond 12 weeks.

N.K. Arora, chairman of the NTAGI working group, said in a statement that the decision to expand the gap to up to 16 weeks had been made to provide "flexibility" for those who may not be able to get the second dose at 12 weeks.
 
UK used the 12 week gap for AZ. Canada too. So why can't India?

Here in Ontario(Canada) people who had 1st dose of AZ are now eligible for Pfizer/Moderna for second dose. My parents got their second dose of Pfizer today after gap of 12+ weeks.

I heard with arrival of more vaccines, wait time will be further reduced. Current wait time is 8 or less weeks for second dose. Canada is among top nation with highest percentage of 1st dose around 66%, which is why we had a bit longer wait time for second dose until past week. I’m getting my second dose tomorrow which will be 7 weeks from 1st dose.

I might be wrong but Public Health of Canada are no longer offering AZ vaccine here.
 
Last edited:
Back
Top